ALTERED LINOLENIC AND LINOLEIC ACID CONTENT IN PLANTS

Abstract: Transformed plants which have increased or decreased linolenic acid content are disclosed. Also disclosed are plants which express a linoleic acid desaturase gene.

Description: ALTERED LINOLENIC AND LINOLEIC ACID CONTENT IN PLANTS This is a continuation-in-part of U.S. Serial No. 08/156,551 filed November 22, 1993, which is a continuation of U.S. Serial No. 5 08/014,431, filed on February 5, 1993. The present invention relates to genetically engineered plants. In particular it relates to genetically engineered plants and seeds which have altered linolenic and linoleic acid content compared with naturally occurring plants. BACKGROUND 10 Many crop species produce seed oils in which the fatty acid composition is not ideally suited to the intended use. The application of conventional breeding methods, coupled in some cases with mutagenesis, has resulted in the production of new varieties of several species with desirable alterations in the fatty acid composition of seed oil. A notable 15 example is the development of low erucic acid varieties of rapeseed (Stefansson 1983). Similar efforts have resulted in the reduction of the level of polyunsaturated 18-carbon fatty acids in soybean (Wilcox and Cavins 1985; Graef et al. 1988), sunflower (Fick 1989), and linseed oils (Green and Marshal 1984). 20 Most of the genetic variation in seed lipid fatty acid composition appears to involve the presence of an allele of a gene that disrupts normal fatty acid metabolism and leads to an accumulation of intermediate fatty acid products in the seed storage lipids (Downey 1987). However, it seems likely that, because of the inherent limitations of this 25 approach, many other desirable changes in seed oil fatty acid composition may require the directed application of genetic engineering methods. Λ α-Linoienic acid (18:3 Δ9 - 12 - 15 ) is an eighteen carbon fatty acid containing three cis double bonds at the 9-10, 12-13 and 15-16 carbons. It is found in the cells of higher plants as a constituent of cell membranes. It is also found in storage organs, such as in seeds. There it is designated oil bodies which are bounded by an electron dense structure that is thought to be a half-unit membrane and dispersed in the cytoplasmic environment of cells. When present as a constituent of cell membranes, linolenic acid is usually esterified to the sn-1 or sn-2 position of the glycerol moiety of a diacyl-glycerolipid. By contrast, when present in oil bodies, linolenic acid is usually esterified to the sn-1, sn-2 or sn-3 position of a triacylglycerolipid (TAG). Linolenic acid is extensively used in the paint and varnish industry in view of its rapid oxidation. Flax seed is a predominant source of this oil. Soybean seed, on the other hand, does not have sufficient linolenic acid content to be used in this industry. Thus, increasing the linolenic acid content in a plant such as soybean would permit the use of the soybean oil in the paint and varnish industry. On the other hand, it is undesirable to have significant levels of linolenic acid in cooking oils and foods. Linolenic acid is unstable during cooking and is rapidly oxidized. The oxidized products impart rancidity to the finished product. A rapeseed or soybean oil with reduced linolenic acid, such as containing 2% or less of linolenic acid, would be ideal for use as a cooking oil. Linolenic acid is also a precursor in the biosynthesis of jasmonic acid, an important plant growth regulator. Linolenic acid is converted to jasmonic acid by introduction of an oxygen to the carbon chain by a lipoxygenase, followed by dehydration, reduction, and several β- oxidations (Vick and Zimmerman, 1984). The activity of jasmonic acid has been measured in terms of induction of pathogen defense responses. By application of free linolenic acid to plants, plant pathogen defenses can also be induced (Farmer and Ryan, 1992). A model has been proposed to explain the ability of free Hnolenic acid to exhibit the effects associated with jasmonic acid (Farmer and Ryan, 1992). It is hypothesized that all of the enzymatic activities which are required for the conversion of Hnolenic acid to jasmonic acid are constitutively present in the cell and the rate limiting step in the production of jasmonic acid is the availability of free linolenic acid. A likely route for the production of the free linolenic acid is by the activity of a lipase in the plasma membrane. It has been observed that exogenous jasmonic acid can more powerfully activate defense responses than can wounding. This suggests that wounds cannot generate enough free linolenic acid to support high level production of jasmonic acid. The activity of the Hpase or the availabiHty of appropriate substrate for the lipase may be rate limiting upon wounding. Thus, increasing the linolenic acid content of plasma membrane may positively influence "signal transduction" in plants and result in better protection against environment and pathogen stress. Linolenic acid, as well as oleic and linoleic acids are also important constituents, as well as precursors of volatile carbonyl compounds, whic contribute to the aroma of both fresh and cooked foods. The major fatty acids of tomato fruit pericarp are oleic, Hnoleic and Hnolenic acids. As the fruit ripens, the levels of the latter two fatty acids decline resulting in the production of a number of 4-6 carbon containing aldehydees and ketones. One particular metabolite, cis-3-hexanol, has been shown to be present in higher levels in vine-ripened tomatoes compared to supermarket tomatoes or tomatoes stored in refrigerators. It is likely, therefore, that the "aroma" of fresh fruits and vegetables can be "modulated" by regulation of the content of linolenic and linoleic acids, important substrates for the enzyme lipoxygenase and subsequently the hydroperoxide cleaving enzyme, which generates the volatile "aroma" compounds. From the above, it is clear that the ability to vary the content of linolenic acid in plants would be desirable. However, to achieve this result it is necessary to determine what controls the product of linolenic acid in plants. A large body of experimental evidence derived from radiochemical tracer studies has indicated that α-linolenic acid is synthesized by the desaturation of linoleic acid (18:2 Δ9 > 12 ) (reviewed in Harwood 1988;). However, the actual substrate for desaturation is not known. In vivo and in vitro labelling studies suggest that there are possibly two distinct pathways for the synthesis of Hnolenic acid (Browse and Somerville, 1991). One possible pathway is thought to be located in the endoplasmic reticulum where Hnoleic acid esterified to the sn-2 position of phosphatidylcholine is a substrate for desaturation. However, the available evidence does not exclude the possibility that linoleic acid esterified to other Hpids may also be a substrate. A second possible pathway of linoleic acid desaturation is located in the plastid where the available evidence suggests that linoleic acid esterified to monogalactosyldiacylglycerol and, possibly, other plastid Hpids is the substrate for desaturation. Relatively little direct information is available concerning the enzymes involved in linoleic acid desaturation. Low levels of enzyme activity have been detected in microsomal membrane preparations from developing linseed (Linum ussitatum) (Browse and Slack, 1981) and, more recently, in preparations of gently lysed chloroplasts (Schmidt and Heinz, 1990a,b). The general features of the enzyme may be inferred from information available about other enzymes of this class. The most thoroughly characterized desaturase is the stearoyl- Coenzyme A (CoA) desaturase from vertebrate liver (reviewed by HoUoway, 1983). This enzyme has been shown to be an integral membrane protein which contains non-heme iron. The desaturase reaction requires fatty acyl-CoA, molecular oxygen and reduced cytochrome b5, another membrane protein. In vivo , the reduced cytochrome b5 is produced by the transfer of reducing equivalents from NADH via the activity of cytochrome b5 reductase, a flavin containing membrane protein. The most thoroughly characterized desaturase from plants is the stearoyl-ACP desaturase (McKeon and Stumpf, 1982; Shanklin and Somerville, 1991). This enzyme also requires molecular oxygen and a high potential reductant. However, in contrast to the animal enzyme, this desaturase is a soluble plastid protein which preferentially acts on a fatty acid esterified to acyl carrier protein (ACP) rather than CoA. This enzyme also differs from the animal enzyme by utilizing reduced ferredoxin as an intermediate electron donor. Other plant desaturases appear to be membrane proteins. The microsomal Δ12 oleate desaturase from several plant species has been assayed in membrane preparations from several plants (Harwood, 1988). As with the stearoyl-CoA desaturase from animals, this enzyme requires molecular oxygen and reduced cytochrome b5 as an electron donor (Kearns et al., 1991). However, it appears that oleate esterified to a phosphoHpid is the substrate rather than a CoA ester. With regard to the activity responsible for the making of Hnolenic acid, little was known as to its source or origin. However, evidence that the amount of linolenic acid is related to the amount of linoleic acid desaturase activity has been obtained by analysis of the properties of the fad3 mutant of Arabidopsis thaliana (Lemieux et al. 1990). This mutant is deficient in linolenic acid in the storage oils of its seed Hpids and in the membrane Hpids of different tissues to varying degrees. The mutant also had an increase in the amount of linoleic acid. This can be interpreted as evidence that the mutant is defective in the activity of a desaturase which converts Hnoleic acid to linolenic acid. There is further evidence to suggest that the activity of this desaturase could be rate Hmiting for Hnolenic acid synthesis under normal circumstances. This was discovered by measuring the effects on fatty acid composition in heterozygous plants (i.e., fad3+/fad-) formed by crossing the wild type with the fad3 mutant. In these Fl plants, which have one copy of the normal fad3 gene product instead of the two normally found in the wild type, the amount of Hnolenic acid was almost exactly intermediate between that found in either parent. This suggests that the amount of Hnolenic acid is proportional to the amount of functional fad3 gene product (Lemieux et al., 1990). These results do not shed any Hght, however, on the nature of the fad3 gene product or whether the observed effects in mutants are related to either a decrease in quantitiy of desaturase protein or desaturase activity due to a defective protein. Moreover, nothing is known with any degree of certainty about the linoleic acid desaturase from plant microsomes. As noted above, very little is known about the microsomal desaturases except that they probably utilize reduced cytochrome b5 as intermediate electron donor and probably utilize Hpids rather than CoA or ACP esters as substrates. Moreover, as in many other aspects of plant biology, the lack of specific information about the biochemistry and regulation of lipid metaboHsm makes it difficult to predict how the introduction of one or a few genes might usefully alter seed lipid synthesis. An additional problem arises from the fact that many of the key enzymes of lipid metabolism are membrane-bound and present in low quantities. Thus, attempts to solubilize and purify them from plant sources have not been successful. SUMMARY OF THE INVENTION The present invention provides structural coding sequences encoding Hnoleic acid desaturase activity which can be used to alter the linoleic and linolenic acid compositions of plants or to isolate other plant linoleic acid desaturases. The present invention further provides a plant capable of expressing a structural coding sequence to control the level of linolenic acid or Hnoleic acid or both in the plant. The present invention further provides a method for controlHng the levels of linoleic and linolenic acid in plants. It is also demonstrated by the present invention that the Hnoleic acid desaturase enzyme activity in plant cells and tissues is a controlHng step in Hnolenic acid biosynthesis. The present invention further relates to the engineering of two advantageous traits into plants: increased and decreased α-linolenic acid content in the structural Hpids or storage oils of various crop plants. In accomplishing the foregoing, there is provided, in accordance with one aspect of the present invention, a genetically transformed plant which has an elevated linolenic acid content comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3 ' end of said RNA sequence. In accordance with another aspect of the present invention, there is provided a genetically transformed plant which has a reduced linolenic acid content, comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a Hnoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. There has also been provided, in accordance with another aspect of the present invention a method of producing a genetically transformed plant which has an elevated or reduced Hnolenic acid content. There has also been provided, in accordance with another aspect of the present invention a recombinant, double-stranded DNA molecule and plant cells containing a recombinant, double-stranded DNA molecule. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 shows the genetic map of the region of chromosome 2 of Arabidopsis thaliana where a linoleic acid desaturase gene is located and the identity of the yeast artificial chromosomes which carry this region of the genome. Figure 2 shows the structure of plasmid pBNDES3 which was obtained by inserting an EcoRI fragment containing the B. napus Hnoleic acid desaturase cDNA (fad3) into pBLUESCRIPT. Figure 3 shows the nucleotide sequence (SEQ ID NO:l) and deduced amino acid sequence (SEQ ID NO:2) for the linoleic acid desaturase cDNA (fad3) from B. napus. Figure 4 shows a comparison of the deduced amino acid sequence of one linoleic acid desaturase cDNA (fad3) from B. napus and the desA gene from Synechocystis. Identical residues are indicated by a solid box. Conservative substitutions are indicated by a stippled box. Figure 5 shows the binary Ti plasmid vector pBI121. Figure 6 shows the binary Ti plasmid pTiDES3 which was constructed by insertion of a linoleic acid desaturase cDNA (fad3) into pBI121. Figure 7 shows the map of the plant transformation vector pMON13804. Figure 8 shows the map of the plant transformation vector pMON13805. Figure 9 shows the oil content of control and transformed canola seed in accordance with the present invention. Figure 10 shows the nucleotide sequence (SEQ ID NO:9) for the Hnoleic acid desaturase cDNA (fadD) from Arabidopsis. Figure 11 shows the deduced amino acid sequence (SEQ ID NO: 10) for the linoleic acid desaturase cDNA (fadD) from Arabidopsis. Figure 12 shows the nucleotide sequence (SEQ ID NO:ll) for the Hnoleic acid desaturase cDNA (fadE) from Arabidopsis. Figure 13 shows the deduced amino acid sequence (SEQ ID NO:12) for the linoleic acid desaturase cDNA (fadE) from Arabidopsis. DETAILED DESCRIPTION OF THE INVENTION A genetically transformed plant of the present invention which has an altered linolenic or linoleic acid content can be obtained by expressing the double-stranded DNA molecules described in this application. The expression of a double-stranded DNA involves transcription of messenger RNA (mRNA) from one strand of the DNA hy RNA polymerase enzyme, and the subsequent processing of the mRNA primary transcript inside the nucleus. This processing involves a 3' non-translated region which adds polyadenylate nucleotides to the 3' end of the RNA. Promoters Transcription of DNA into mRNA is regulated by a region of DNA usually referred to as the "promoter." The promoter region contains a sequence of bases that signals RNA polymerase to associate with the DNA, and to initiate the transcription of mRNA using one of the DNA strands as a template to make a corresponding complementary strand of RNA. Any promoter which is known or is found to cause transcription of RNA in plant cells can be used in the present invention. Promoters which are useful in the present invention include any promoter that functions in a plant cell to cause the production of a RNA sequence. A number of promoters which are active in plant cells and are capable of producing a RNA sequence have been described in the literature. These include the nopaline synthase (NOS) and octopine synthase (OCS) promoters (which are carried on tumor-inducing plasmids of Agrobacterium tumefaciens), the caulimovirus promoters such as the cauliflower mosaic virus (CaMV) 19S and 35S and the figwort mosaic virus 35S-promoters, the light-inducible promoter from the small subunit of ribulose-l,5-bis- phosphate carboxylase (ssRUBISCO, a very abundant plant polypeptide), and the chlorophyll a b binding protein gene promoter, etc. All of these promoters have been used to create various types of DNA constructs which have been expressed in plants; see, e.g., PCT publication WO 84/02913 (Rogers et al., Monsanto). Promoters may be obtained from a variety of sources such as plants and plant viruses. Promoters can be used in the form that they exist as isolated from plant genes such as ssRUBISCO genes, or can be modified to improve their effectiveness, such as with the enhanced CaMV35S promoter. Those skilled in the art will recognize that the amount of linoleic acid desaturase needed to induce the desired alteration in linolenic acid content may vary with the type of plant. It is also possible that extremes in linoleic acid desaturase activity may be deleterious to the plant. Therefore, in a preferred embodiment, promoter function should be optimized by selecting a promoter with the desired tissue expression capabilities and approximate promoter strength and selecting a transformant which produces the desired Hnoleic acid desaturase activity in the target tissues. This selection approach from the pool of transformants is routinely employed in expression of heterologous structural genes in plants since there is variation between transformants containing the same heterologous gene due to the site of gene insertion within the plant genome. (Commonly referred to as "position effect"). In a preferred embodiment, the promoters utiHzed in the double- stranded DNA molecules should have relatively high expression in tissues where the increased or decreased linolenic acid content is desired, such as the seeds of the plant. In Canola, a particularly preferred promoter in this regard is the seed specific promoter described herein in greater detail in the accompanying examples. In another preferred embodiment, the promoter used in the expression of the double-stranded DNA molecules of the present invention can be a constitutive promoter, expressing the DNA molecule in all or most of the tissues of the plant. However, the promoter selected for this embodiments should not cause expression at levels which are detrimental to plant health, growth and development. β-conglycinin (also known as the 7S protein) is one of the major storage proteins in soybean (Glycine max) (Meinke et al., 1981). The 7S (β- conglycin) α'-subunit promoter, used in one aspect of this study to express the linoleic acid desaturase gene, has been shown to be both highly active and seed-specific (Doyle et al, 1986 and Beachy et al., 1985). The β-subunit of β-conglycinin has been expressed, using its endogenous promoter, in the seeds of transgenic petunia and tobacco, showing that the promoter functions in a seed-specific manner in other plants (Bray et al., 1987). The promoter for β-conglycinin could be used to in accordance with the present invention. If used, this promoter could express the DNA molecule specifically in seeds, which could lead to an alteration in the Hnolenic acid content of the seeds. In addition, the endogenous plant linoleic acid desaturase promoters can be used in the present invention. These promoters should be useful in expressing a linoleic acid desaturase gene in specific tissues, such as leaves, seeds or fruits. A number of other promoters with seed-specific or seed-enhanced expression are known and are likely to be expressed in seeds, which are oil accumulating cells. For illustration, the napin promoter and the acyl carrier protein promoters have been utilized in the modification of seed oil by antisense expression (Knutson et al., 1992). The linolenic acid content of root tissue can be increased by expressing a linoleic acid desaturase gene behind a promoter which is expressed in roots. The promoter from the acid chitinase gene (Samac et al., 1990) is known to function in root tissue and could be used to express the Hnoleic acid desaturase in root tissue. Expression in root tissue could also be accomplished by utilizing the root specific subdomains of the CaMV35S promoter that have been identified. (Benfey et al., 1989). The linolenic acid content of leaf tissue can be increased by expressing the linoleic acid desaturase gene using a leaf active promoter such as ssRUBISCO promoter or chlorophyll a/b binding protein gene promoter. The linolenic acid content of fruits can be increased by expressing a linolenic acid desaturase gene behind a promoter which is functional in fruits. Such promoters could be either expressed at all developmental stages of the fruit or restricted to specific stages, particularly fruit ripening. The RNA produced by a DNA construct of the present invention can also contain a 5' non-translated leader sequence. This sequence can be derived from the promoter selected to express the gene, and can be specifically modified so as to increase translation of the mRNA. The 5' non-translated regions can also be obtained from viral RNAs, from suitable eukaryotic genes, or from a synthetic gene sequence. The present invention is not limited to constructs, as presented in the following examples, wherein the non-translated region is derived from the 5' non- translated sequence that accompanies the promoter sequence. Rather, the non-translated leader sequence can be derived from an unrelated promoter or coding sequence as discussed above. Linoleic Acid Desaturase Structural Coding Sequences The structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity can be the sequences disclosed in the present application, or any sequence that can be obtained using the sequences disclosed in the present application, or any sequence that can be isolated using the method disclosed in the present apphcation. The structural coding sequence can also be a part of or from the structural coding sequences disclosed in the present invention. It is possible that the active part of the Hnoleic acid desaturase is formed using only part of the structural coding sequences disclosed in the present application. The structural coding sequences can be obtained from a variety of sources, such as algae, bacteria or plants. Preferably, structural coding sequences obtained from plants are used in accordance with the present invention. Since virtually nothing was known about the properties of the linoleic acid desaturase structural coding sequence prior to the present invention, the method used in the present invention to isolate the structural coding sequence was based on the concept of map based cloning. The essential concept in map based cloning is to use information about the genetic map position of a structural coding sequence to isolate the region of the chromosome surrounding the structural coding sequence, and then to use the isolated DNA to complement a mutation in the structural coding sequence. This strategy has never previously been reported in the isolation of any plant gene. In order to implement map based cloning of the linoleic acid desaturase, mutants of Arabidopsis thaliana (L.) deficient in linoleic acid desaturase activity were isolated by screening randomly chosen individuals from mutagenized populations of plants for individual plants with altered leaf or seed fatty acid composition. (Browse et al. 1985; Lemieux et al. 1990). By screening thousands of plants for altered fatty acid composition, mutants with decreased amounts of linolenic acid and increased amounts of linoleic acid in leaf and seed Hpids were isolated. Physiological and genetic analyses of these mutants indicated that they fell into three complementation groups designated fad3, fadD and fadE. The fad3 mutants had very reduced levels of linolenic acid in seeds and roots but had almost normal levels of linolenic acid in leaves. This effect was interpreted as evidence that the fad3 locus encoded a microsomal desaturase which was responsible for desaturation of linoleic acid to Hnolenic acid on Hpids made by the pathway of Hpid biosynthesis in the endoplasmic reticulum, designated the "eukaryotic pathway" (Lemieux et al. 1990). This pathway is mostly responsible for the synthesis of Hpids in non-green tissues such as seeds and roots, but plays a secondary role in leaves and other green tissues. Thus, a mutation in the fad3 gene would not be expected to have a major effect on the desaturation of leaf Hpids. In contrast to the fad3 mutant, the fadD mutant had almost normal fatty acid composition of roots and seeds, but had a strong reduction in the amount of Hnolenic acid in leaf Hpids, and a corresponding increase in the amount of linoleic acid. (Browse et al., 1986). Thus, this mutant had the properties expected of a mutant deficient in a Hnoleic acid desaturase from the prokaryotic pathway which is primarily responsible for the synthesis of Hpids in green tissues. An unusual property of the fadD mutants was that they were very deficient in linoleic acid content when grown at temperatures above about 22 °C but had almost normal fatty acid composition when grown at temperatures below about 18 °C (McCourt et al., 1987). Since it was very unlikely that several independently isolated mutations would aU give rise to a temperature conditional phenotype, it was concluded that a second desaturase must be partially responsible for desaturating linoleic acid to linolenic acid in green tissues. Therefore, the fadD mutant was remutagenized with ethylmethane sulfonate, self-fertilized to produce a segregating population of mutagenized plants (designated the M2 generation), and this population was screened for a mutant which was deficient in linolenic acid in green tissues at low temperatures. A mutant with this property was isolated and the mutation responsible for this effect was designated the fadE locus (Somerville and Browse, unpubHshed). Isolation of the Linoleic Acid Desaturase Gene from Canola The following example was used to isolate the structural coding sequence from the fad3 region. The method described herein could equally have been used to isolate either the fadD or fadE region. In order to approximately locate the fad3 mutation of the genetic map of Arabidopsis, a sexual cross was made between the fad3 mutant Hne BLl and the multiply marked mutant Hne Wl (Hugly et al., 1991). The Fl hybrids from this cross were permitted to self-fertiHze and the resulting F2 plants were scored for both the segregating genetic markers and the altered fatty acid composition. The results of this analysis indicated that the fad3 mutation was located on chromosome 2 near the marker erecta. In order to obtain a more accurate map position by RFLP mapping, a second sexual cross was made between the fad3 mutant line BLl and the Niederzenz race of Arabidopsis. The Fl progeny were permitted to self-fertilize to produce the F2 generation. 137 F2 plants were grown during 3 weeks at 22° C (100 μE/m 2 /s) in order to produce fully expanded rosettes, and a few leaves (representing a total weight of 0.2-0.5 g per plant) were harvested from each plant in order to prepare DNA from them. The leaves were frozen in liquid nitrogen, and ground in dry ice, using a mortar and a pestle. For each sample, the frozen powder was transferred to a microfuge tube and an equal amount of 2 X CTAB buffer (2% cetyltrimethyl ammonium bromide (CTAB), 100 mM Tris-HCl pH 8, 20 mM EDTA, 1.4 M NaCl, 1% polyvinylpolypyrroHdone (PVP) 40,000) was added. The tubes were left at room temperature for 5 min to allow the powder to thaw. The homogenate was extracted once with a mixture of chloroform-isoamyl alcohol (24:1, v/v), and 1/10 vol of 10 X CTAB (10 % CTAB, 0.7 M NaCl) buffer was added to the aqueous phase, which was then reextracted with an equal volume of chloroform isoamyl alcohol (24:1, v/v). The aqueous phase was transferred to a fresh microfuge tube and 1.5 vol of CTAB precipitation buffer (1% CTAB, 50 mM Tris-HCl pH 8, 10 mM EDTA) was added. The DNA was allowed to precipitate for 12 hr at 4 degrees, and collected by centrifugation (5 min at 10 OOOg). The DNA was resuspended in 100 μl of 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 M NaCl, and 100 μg/ml RNase A and incubated at 50°C for 30 min. The DNA was precipitated by adding 2.2 vol of ethanol and incubating on ice for 20 min. The DNA was collected by centrifugation and the pellet was washed once with 1 ml of 70% ethanol, dried xmder vacuum for 3 min and resuspended in 10 μl of distilled water. The DNA was stored at -20°C until use. The 137 plants were grown to maturity and their seeds were collected individually. The fatty acid composition of 10 individual seeds from each of the F2 plants was measured as described by Browse et al (1986) in order to score the fad3 phenotype of each plant. Each seed was incubated in 1 ml of IN HCI in methanol for lh at 80°C. The tubes were cooled to room temperature and 1 ml of 0.9 % NaCl plus 0.3 ml of hexane were added. The tubes were agitated by vortexing and the phases separated by centrifugation (300xg for 5 min). The hexane phase was saved, evaporated under a stream of nitrogen, and the fatty acid methyl esters were dissolved in 50 μl hexane. An aliquot (2 μl) was injected onto the gas chromatograph and the fatty acid methyl esters separated and quantitated by flame ionization as described (Browse et al., 1986). The DNA samples (1 μg) were then cut with the appropriate restriction enzyme (EcoRl for the marker # 220, Bgl2 for the marker ASA2) using a concentration of 1XKGB buffer (Sambrook et al, 1989), 5 units of the restriction endonuclease and 100 μg/ml BSA. The volume of. each sample was 10 μl and the incubation was performed at 37 °C for 4 h. The fragments were resolved by agarose gel electrophoresis (0.8 % agarose in IX TAE buffer; Sambrock et al., 1989) and transferred to nylon filters (hybond N+), using the alkaline transfer method as described by the manufacturer. The nylon filters were probed (according to Church and Gilbert, 1984) with radioactively labelled fragments of DNA (Sambrock et al., 1989) corresponding to known RFLP markers which had previously been mapped in the approximate vicinity of the fad3 locus on chromosome 2. The RFLP markers 220 (Chang et al 1988) and ASA2 were found to map close to the fad3 locus. Analysis of the pattern of recombinants (Table 1) indicated that both ASA2 and 220 were located on the same side of the fad3 locus at distances of 0.4 and 2.2 centimorgans (cM), respectively. Table 1 Table 1 shows the genotype of the F2 plants used for mapping the fad 3 locus. L is for Landsberg (background of the fad 3 mutant), N is for Niederzenz, H for heterozygous. A total of 137 F2 plants were analyzed. The number of recombinant plants between fad3 and 220 or ASA2 was 6 and 1 respectively. In order to isolate the region of the chromosome containing the fad3 locus, the RFLP markers 220 and ASA2 were used as hybridization probes to screen several yeast artificial chromosome (YAC) libraries. (Grill and Somerville, 1991; Ward and Jen, 1990). The YAC filters were prepared according to Grill and Somerville (1991). The library was replicated onto nylon filters disposed on petri dishes of SC — (synthetic complete medium minus tryptophan and uracil; Sherman et al., 1986). The ceUs were allowed to grow for 12 h at 30°C, and the filters were transferred for 15 min on a Whatman 3MM paper saturated with 1 M sorbitol, 50 mM DTT, 50 mM EDTA (pH 8). The cell wall of the cells was then digested with lyticase, by incubating the filters on a Whatman paper saturated with 1M sorbitol, 50 mM EDTA and 2 mg/ml lyticase (Sigma Co., St. Louis,MO) for 12 h at 30°C. The filters were then transferred on a Whatman 3MM paper saturated with 0.5 M NaOH, 1.5 M NaCl for 15 min, neutraHzed with 0.5 M Tris-HCl pH 8 for 15 min and quickly rinsed in 2XSSC (SSC is lOmM sodium citrate, 150mM NaCl, pH 7). The filters were allowed to dry, and were transferred to a vacuum oven at 80°C for 1 h. They were subsequently hybridized according to Church and Gilbert (1984), with probes labelled with 32p according to Sambrook et al. (1989). The DNA of RFLP probe 220 was prepared from 100 ml of liquid culture lysate using the lambdasorb procedure (Promega Corp., Madison, WI); the cDNA encoding ASA2 was excised from the original plasmid (pKN140C; obtained from Dr. G. Fink, Whitehead Institute, Cambridge, MA) with Hind3 and cloned into the Hind3 site of pBLUESCRIPT. The plasmid DNA was then purified by Cesium chloride gradients according to Sambrook et al (1989), digested with Hind3 and the DNA insert was gel purified twice by electroelution according to Sambrook et al (1989). In order to probe the libraries, the whole DNA from RFLP220 was used as a hybridization probe. By contrast, only the DNA insert of ASA2 was used as a probe. The RFLP probe 220 hybridized to YAC EG4E8 and EG9D12. The probe ASA2 hybridized to YACs EW15G1, EW15B4 and EW7D11. In order to determine if these YACs contained all of the DNA between RFLP220 and ASA2, small regions of DNA from the ends of the inserts in EG4E8 and EW15G1 were prepared by inverse PCR (Grill and Somerville, 1991). For that purpose, DNA was prepared from the appropriate YAC clones. The clones (single colonies) were grown to saturation in SC — liquid cultures, and 1 ml of these cultures was used to inoculate 40 ml Hquid cultures (in SC — medium) that were allowed to grow for 16 h at 30"C. The cells were collected by centrifugation, washed once in 1 M sorbitol, 50 mM EDTA, resuspended in 200 μl of 1 M sorbitol, 50 mM EDTA, 100 mM sodium citrate pH 5.8, 2 mM β-mercaptoethanol and 2 mg ml lyticase, and incubated 2 h at 30 °C. Next, 350 μl of 2XCTAB buffer was added and the DNA was purified as described above. DNA (5 μg) of each clone was digested separately with Hindi, Alul, EcoRV and Rsal (in 1XKGB buffer, at 37 °C for 4 h; final volume: 50 μl). The reactions were stopped by heating at 65 "C for 15 min, extracted once with one volume of phenol saturated with TE pH 8, followed by an extraction with 1 volume of chloroform - isoamyl alcohol mixture (24:1, vol/vol). The DNA was recovered by ethanol precipitation and resuspended in sterile distilled water. The ligation reactions were performed using 300 ng of DNA in a final volume of 50 μl. The reactions were carried out in 50 mM Tris-HCl pH 7.4, 10 mM MgC12, 1 mM DTT,1.2 mM ATP with 1 U of ligase, for 2 h at 20 °C, and stopped by heating at 68 °C for 30 min. The PCR reactions were carried out as follows: The buffers used were the ones indicated by the suppliers except for the Perkin Elmer enzyme for which the reaction was supplemented with an additional 1.4 mM M Cl 2 (final concentration 2.9 mM Mg). The dNTP final concentration was 125 μM when the Perkin Elmer enzyme was used and 200 μM with the Taq polymerases from other sources. In all cases, 100 ng of each oHgonucleotide was used. The final volume was 100 μl. When no product was obtained, the reactions were carried out again in the same conditions except that formamide was added to a final concentration of 3 %. The left end was amplified from the ligation products of the EcoRV and Rsal digests, using the oHgonucleotides EG1 (GGCGATGCTGTCGGAATGGACGATA) (SEQ. ID NO. 3) and EG2 (CTTGGAGCCACTATCGACTACGCGATC) (SEQ. ID NO. 4). The right end of the clones obtained from the EG library was ampHfied from the ligation products of the Alul and Hindi digests, using the oHgonucleotides EG3 (CCGATCTCAAGATTACGGAAT) (SEQ. ID NO. 5) and EG4 (TTCCTAATGCAGGAGTCGCATAAG) (SEQ. ID NO. 6). The right end of the clones obtained from the EW YAC library was amplified using the oHgonucleotides HI (AGGAGTCGCATAAGGGAG) (SEQ. ID NO. 7) and H2 (GGGAAGTGAATGGAGAC) (SEQ. ID NO. 8), using the same cycle conditions as above, except that the annealing temperature was reduced to 50 °C. After the reactions were completed, 5μl of each mixture were electrophoresed on an agarose gel to separate the amplification product from primers. The slice of agarose that contained the amplified band was excised from the gel and melted in 1 ml of distilled water. Large amounts of product could then be produced, by reamplification of 5 μl of the melted slice. The PCR products were then purified by electroelution or by using GeneClean (Bio 101) and used as hybridization probes to probe filters containing the isolated YAC DNA restricted by several enzymes. The probe made from the right end of EW15G1 hybridized to EG4E8 and similarly, a probe from the right end of EG4E8 hybridized to EW15G1. Thus, it was concluded that the YACs EG4E8 and EW15G1 contained all of the DNA in the region of the chromosome between RFLP220 and ASA2. The size of the YAC clones was estimated by field inversion electrophoresis (CHEF, Vollrath and Davis, 1987). High molecular weight DNA was prepared as follows: the yeast cells which contained the YAC clones were grown and treated with lyticase as for preparing DNA as described above. The spheroplasts were then resuspended in an equal volume of 1M sorbitol, 50 mM EDTA, 1 % low melt agarose at 37°C. The mixture was poured in a mould (Biorad) which was set on ice to allow the agarose to harden. The resulting plugs were incubated for 12 h in 0.5 M EDTA pH 9, 1% lauryl sarcosine 1 mg/ml Proteinase K at 50°C. The plugs were subsequently washed twice in 50 mM EDTA and stored at 4°C until use. The CHEF gel was run in 1XTBE for 16 h at 200 V, with a switching interval of 20 s; the temperature of the buffer was maintained at 14 °C during the run. The sizes of the YACs were determined by comparison with a lambda ladder and the yeast chromosomes, and were as follows: EG4E8, 90 kb; EG9D12, 190 kb; EW15G1, 90 kb; EW15B4, 70 kb, EW7D11, 125 kb. These sizes permitted us to roughly determine a correspondence between physical and genetic distances: the distance that separates 220 from ASA2 cannot exceed 180 kb, the sum of the size of the 2 YACs EG4E8 and EW15G1. Since the corresponding genetic distance is 1.7 cM, one can roughly estimate that, in this particular cross and in this particular region of the genome, the value of 1 cM is close to lOOkb. Thus, since the fad3 gene maps only 0.4 cM away from ASA2, the corresponding physical distance should be close to 40 kb. We then concluded that fad3 was probably located on the YAC EW7D11, which is the largest YAC hybridizing with ASA2. See Figure 1. In order to test the possibility that the YAC EW7D11 carried the fad3 gene, the YAC was used to probe a cDNA library made from developing seeds of Canola (Brassica napus L.). Even though the YAC was isolated from Arabidopsis, the fact that Arabidopsis and B. napus are both members of the family Cruciferae led us to predict that the homologous genes from these two species would be sufficiently identical at the nucleotide sequence level so that the Arabidopsis gene would hybridize to the B. napus gene. We also assumed that, because it catalyzes a chemically similar reaction to the stearoyl-ACP desaturase, it would be expressed at similar moderately high levels in developing seeds (ShankHn and Somerville, 1991). Since EW7D11 contained only about 0.2% of the total genome, we expected it to contain only about 2 moderately abundantly expressed genes (i.e., genes in which the mRNA is between 0.1 and 0.01% of total mRNA). DNA of YAC EW7D11 was isolated as follows: high molecular weight DNA was prepared from the yeast cells that contained the YAC EW7D11 as described above, and several preparative low-melt agarose CHEF gels were run in 1XTBC buffer (same as TBE except that CDTA was substituted for EDTA). The slices that contained the YAC were excised from the gels and pooled. Three slices were melted at 65°C and extracted with an equal volume of phenol saturated with TE. The aqueous phase was saved and reduced to 0.5 ml by repeated extractions with isobutyl alcohol. The remaining agarose was removed by several phenol extractions, followed by two chloroform-isoamyl alcohol extractions. The DNA was precipitated by adding 2 μg of Hnear acrylamide as a carrier plus 10 μl of 5M NaCl and 1.1 ml of ethanol, and incubating 20 min at 0 °C. The DNA pellet was recovered by centrifugation, washed in 70% ethanol, dried under vacuum and resuspended in 50 μl of distilled water. The DNA (50 ng) was radioactively labelled and used to probe a cDNA Hbrary in λgtll. The nitrocellulose filters were processed as described in Sambrook et al (1989). Duplicate filters were used, and the films were exposed 5-7 days in order to obtain a good signal. From among 200,000 plaques screened in this way, 31 hybridized to EW7D11. Among these 31 clones, 17 were homologous to each other, as checked by cross hybridization in stringent conditions. The size of the inserts in the 17 clones was estimated and the clone with the largest cDNA was retained for further analysis. A small scale preparation of this phage was prepared using the lambdasorb method, and the insert was excised by restricting with EcoRl. This insert was Hgated into a pBLUESCRIPT II vector Hnearized with EcoRl, and the Hgation mixture was used to transform E. coH strain DH5α. One of the recombinant clones was designated pBNDES3 (Figure 2), and retained for sequencing. The sequence was determined on both strands, using the sequenase enzyme, (US Biochemicals, Cleveland, OH) according to the instructions provided by the supplier. The nucleotide sequence of the insert in pBNDES3 is presented as Figure 3. The deduced amino acid sequence of the largest open reading frame in the nucleotide sequence is also shown in Figure 3. Comparison of the deduced amino acid sequence of the 383 amino acid open reading frame in clone pBNDES3 against the known sequences in GenBank release 70 was performed using the FASTA program (Lipman and Pearson, 1985). This analysis revealed that the sequence from pBNDES3 had a region of significant homology to a previously characterized desaturase gene from the cyanobacterium Synechocystis (Figure 4). (Wada et al. 1990). This was considered suggestive evidence that the clone pBNDES3 encoded a desaturase which was probably the fad3 structural coding sequence product. This was subsequently confirmed by a genetic complementation experiment. The cDNA was cloned into plant transformation vector pBI121 (Figure 5) under the control of the CaMV35S promoter to construct pTiDES3 (Figure 6). Plasmid pTiDES3 was introduced into an Agrobacterium tumefaciens strain which also carried an Ri plasmid and this was used to produce transgenic rooty tumors from both wild type Arabidopsis and the fad3 mutant. Transgenic tissue was selected for antibiotic resistance to confirm the presence of the pTiDES3. Fatty acid methyl esters were then prepared and examined by gas chromatography to determine the profile of fatty acids being produced in the tissue. The levels of linolenic acid increased, demonstrating that the cDNA on pTiDES3 can complement the fad3 mutation. These results, which are described in detail in Example 1 below, confirm the identity of the cDNA as encoding a Hnoleic acid desaturase. The isolation of a plant structural coding sequence provides those skilled in the art with a tool for the manipulation of gene expression by the mechanism of antisense RNA. The technique of antisense RNA is based upon introduction of a chimeric gene which will produce an RNA transcript that is complementary to a target gene (reviewed in Bird and Ray, 1991). The resulting phenotype is a reduction in the gene product from the endogenous gene. The portion of the gene which is sufficient for achieving the antisense effect is variable in that numerous fragments or combinations thereof are likely to be effective. Various portions of the structural coding sequence of linoleic acid desaturase isolated either from cDNA or genomic clones are Hkely capable of reducing Hnolenic acid levels in plants by reduction in levels of Hnoleic acid desaturase levels. An example of using an antisense oriented linoleic acid desaturase structural coding sequence is set out in Example 2. Polvadenylation Signal The 3' non-translated region of the double stranded DNA molecule of the present invention contains a region that functions in plant cells to promote polyadenylation to the 3' end of the RNA sequence. Any such regions can be used within the scope of the present invention. Examples of suitable 3' regions are (1) the 3' transcribed, non-translated regions containing the polyadenylated signal of Agrobacterium tumor- inducing (Ti) plasmid genes, such as the nopaline synthase (NOS) gene, and (2) 3' regions of plant genes Hke the soybean storage protein genes and the small subunit of the ribulose-l,5-bisphosphate carboxylase (ssRUBISCO) gene. An example of a preferred 3' region is that from the NOS gene, described in greater detail in the examples below. Plant Transformation/Regeneration Any plant which can be transformed to contain the double- stranded DNA molecule of the present invention are included within the scope of this invention. Preferred plants which can be made to have increased or decreased linolenic acid content by practice of the present invention include, but are not limited to sunflower, safϊlower, cotton, corn, wheat, rice, peanut, canola/oilseed rape, barley, sorghum, soybean, flax, tomato, almond, cashew and walnut. A double-stranded DNA molecule of the present invention containing the functional plant Hnoleic acid desaturase gene can be inserted into the genome of a plant by any suitable method. Suitable plant transformation vectors include those derived from a Ti plasmid of Agrobacterium tumefaciens, as well as those disclosed, e.g., by Herrera- Estrella (1983), Bevan (1984), Klee (1985) and EPO publication 120,516 (Schilperoort et al.). In addition to plant transformation vectors derived from the Ti or root-inducing (Ri) plasmids of Agrobacterium, alternative methods can be used to insert the DNA constructs of this invention into plant cells. Such methods can involve, for example, the use of liposomes, electroporation, chemicals that increase free DNA uptake, free DNA delivery via microprojectile bombardment, and transformation using bacteria, viruses or pollen. A plasmid expression vector, suitable for the expression of the linoleic acid desaturase gene in monocots is composed of the following: a promoter that is specific or enhanced for expression in the lipid storage tissues and a 3' polyadenylation sequence such as the nopaline synthase 3' sequence (NOS 3'; Fraley et al., 1983). This expression cassette may be assembled on high copy replicons suitable for the production of large quantities of DNA. A particularly useful Agrobacterium-based plant transformation vector for use in transformation of dicotyledonous plants is plasmid vector pMON530 (Rogers, S.G., 1987). Plasmid pMON530 (see Figure 7) is a derivative of pMON505 prepared by transferring the 2.3 kb StuI-HindlH fragment of pMON316 (Rogers, S.G., 1987) into pMON526. Plasmid pMON526 is a simple derivative of pMON505 in which the Smal site is removed by digestion with Xmal, treatment with Klenow polymerase and Hgation. Plasmid pMON530 retains all the properties of pMON505 and the CaMV35S-NOS expression cassette and now contains a unique cleavage site for Smal between the promoter and polyadenylation signal. Vector pMON505 is a derivative of pMON200 (Rogers, S.G., 1987) in which the Ti plasmid homology region, LIH, has been replaced with a 3.8 kb Hindlll to Smal segment of the mini RK2 plasmid, pTJS75 (Schmidhauser & HeHnski, 1985). This segment contains the RK2 origin of replication, oriV, and the origin of transfer, oriT, for conjugation into Agrobacterium using the tri-parental mating procedure (Horsch & Klee, 1986). Plasmid pMON505 retains all the important features of pMON200 including the synthetic multi-Hnker for insertion of desired DNA fragments, the chimeric NOS/NPTII'/NOS gene for kanamycin resistance in plant cells, the spectinomycin streptomycin resistance determinant for selection in E. coli and A. tumefaciens, an intact nopaline synthase gene for facile scoring of transformants and inheritance in progeny and a pBR322 origin of replication for ease in making large amounts of the vector in E. coli. Plasmid pMON505 contains a single T-DNA border derived from the right end of the pTiT37 nopaline-type T-DNA. Southern analyses have shown that plasmid pMON505 and any DNA that it carries are integrated into the plant genome, that is, the entire plasmid is the T-DNA that is inserted into the plant genome. One end of the integrated DNA is located between the right border sequence and the nopaline synthase gene and the other end is between the border sequence and the pBR322 sequences. When adequate numbers of cells (or protoplasts) containing the linoleic acid desaturase gene are obtained, the cells (or protoplasts) are regenerated into whole plants. Choice of methodology for the regeneration step is not critical, with suitable protocols being available for hosts from Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed, etc.), Cucurbitaceae (melons and cucumber), Gramineae (wheat, rice, corn, etc.), Solanaceae (potato, tobacco, tomato, peppers) and various floral crops. See, e.g., Ammirato (1984); Shimamoto, 1989; Fromm, 1990; Vasil and Vasil, 1990. Uses of Linoleic Acid Desaturase The present invention can be used for any modification (either increase, decrease, or mere change) of the oil content of a plant or plant tissue. Linolenic acid is an important constituent of several membranes in plant cells. One preferred method is to modify the oil content of the plant to improve the plant's temperature sensitivity. For instance, plants deficient in linolenic acid display reduced fitness at low temperature (Hugly and Somerville, 1992). Also, increased Hnoleic acid content in vegetative tissues has been implicated as a factor in freezing tolerance in higher plants (Steponkus et al., 1990 and references therein). In a preferred embodiment, expression of the linoleic acid desaturase structural coding sequence can result in the genetic modification of higher plants to achieve tolerance to low environmental temperatures. Transformation with pTiDES3 demonstrates that linolenic acid levels can be increased by expression of this gene in a constitutive manner. ChilHng or freezing injury in crops may be overcome by expression of this gene in vegetative or reproductive tissues by employing an appropriate promoter. Linolenic acid, a polyunsaturated fatty acid, is also extensively used in the paint and varnish industry in view of its rapid oxidation. Flax seed is a predominant source of this oil. Higher quantities of this fatty acid in rapeseed or soybean will provide opportunities for using vegetable oils from these sources as a replacement for linseed (flax) oil. Expression of a Hnoleic acid desaturase structural coding sequence in seed tissue can result in a higher proportion of Hnolenic acid in the storage oil. Linolenic acid is further a precursor in the biosynthesis of jasmonic acid, an important plant growth regulator. Linolenic acid is converted to jasmonic acid by introduction of an oxygen to the carbon chain by a lipoxygenase, followed by dehydration, reduction, and several β- oxidations (Vick and Zimmerman, 1984). The activity of jasmonic acid has been measured in terms of induction of pathogen defense responses. By application of free linolenic acid to plants, plant pathogen defenses can also be induced (Farmer and Ryan, 1992). A model has been proposed to explain the ability of free linolenic acid to exhibit the effects associated with jasmonic acid (Farmer and Ryan, 1992). It is hypothesized that all of the enzymatic activities which are required for the conversion of linolenic acid to jasmonic acid are constitutively present in the cell and the rate limiting step in the production of jasmonic acid is the availability of free linolenic acid. A likely route for the production of the free linolenic acid is by the activity of a Hpase in the plasma membrane. It further has been observed that exogenous jasmonic acid can more powerfully activate defense responses than can wounding. This suggests that wounds cannot generate enough free Hnolenic acid to support high level production of jasmonic acid. The activity of the lipase or the availability of appropriate substrate for the lipase may be rate limiting upon wounding. By increasing levels of available substrate, increasing linolenic acid levels in the plasma membrane, it should be possible to enhance a plant's ability to respond to pathogens by allowing for a higher production of jasmonic acid. Expression of a linoleic acid desaturase structural coding sequence can result in a higher molar percent linolenic acid in the plasma membrane of a plant cell therefore enhancing the jasmonic acid signaling pathway. It is our intent to evaluate plants containing high linolenic acid levels in root and foliar tissues for their pathogen resistance. It is also undesirable to have significant levels of linolenic acid in cooking oils. Linolenic acid is unstable during cooking and is rapidly oxidized. The oxidized products impart rancidity to the finished product. Rapeseed or soybean oil containing less than about 3%, and preferably 2% or less of linolenic acid is ideal for use as a cooking oil. By expression of the antisense of the structural coding sequence for linoleic acid desaturase, it is possible to reduce the linolenic acid content of these oils. All higher plants have linolenic acid and, therefore, contain genes for Hnoleic acid desaturases. Because of the many examples in which genes isolated from one plant species have been used to isolate the homologous genes from other plant species, it is apparent to any one skilled in the art, that the results presented here do not only pertain to the use of the B. napus fad3 gene, or to the use of the gene to modify fatty acid composition in B. napus . Obviously, the Hnoleic acid desaturases from many organisms could be used to increase Hnolenic acid biosynthesis and accumulation in plants and enzymes from any other higher plant or algae can serve as sources for linoleic acid desaturase genes. For example, since a YAC containing the Arabidopsis gene was used to isolate the B. napus gene, it is apparent that the insert in pBNDES3 could be used as a probe of genomic Hbraries for isolation of the corresponding full length genes from other plant species. It is also likely that the information contained in the sequence of this gene will be useful to clone other Hpid desaturases genes. Expression of a linoleic acid desaturase in a sense orientation may also allow for the isolation of plants with reduced levels of linolenic acid. This could be accompHshed by the mechanism of co-suppression (Bird and Ray, 1991). The molecular mechanism of co-suppression is at this time poorly understood but occurs when plants are transformed with a gene that is identical or highly homologous to an allele found in the plants genome. There are several examples where expression of a chimeric gene in plants can result in a reduction of the gene product from both the chimeric gene and the endogenous gene(s). Those skilled in the art will recognize that the resulting decrease in linolenic acid would be a direct result of expression of the linoleic acid desaturase structural coding sequence and would be correlated to the Hnoleic acid desaturase activity in the transformed plant. Linolenic acid levels in plant cells can also be modified by isolating genes encoding transcription factors which interact with the upstream regulatory elements of the plant linoleic acid desaturase gene(s). Enhanced expression of these transcription factors in plant cells can effect the expression of the linoleic acid desaturase gene. Under these conditions, the increased or decreased linolenic acid content would also be caused by a corresponding increase or decrease in the activity of the linoleic acid desaturase enzyme although the mechanism is different. Methods for the isolation of transcription factors have been described (Katagiri, 1989). The following examples are provided to better elucidate the practice of the present invention and should not be interpreted in any way to limit the scope of the present invention. Those skilled in the art will recognize that various modifications, truncations, etc. can be made to the methods and genes described herein while not departing from the spirit and scope of the present invention. Example 1 Expression of fad3 gene to increase Hnolenic acid To verify the assumption that the cDNA insert in pBNDES3 encodes a linoleic acid desaturase, both wild type and fad3 mutation Arabidopsis were transformed to contain the cDNA insert. In order to express the linoleic acid desaturase structural coding sequence (hereafter referred to as the "fad3 gene") in plant cells, the plasmid pBNDES3 was digested with Xhol and the ends were filled in with the Klenow fragment of DNA polymerase (Sambrook et al 1989). The cDNA insert was subsequently excised by digestion with Sacl and Hgated into the Sacl and Smal sites of the binary Ti plasmid vector pBI121 (Clontech Laboratories), thereby replacing the GUS reading frame. The ligation reaction was carried out in 20 μl for 12 h at 16 °C using 100 ng of both insert and vector, and one unit of T4 DNA ligase. The ligation mixture was used to transform competent DHδo E. coli cells (prepared by the calcium chloride method, according to Sambrook et al, 1989), and transformants were selected on L-broth plates that contained 50 μg/μl Kanamycin. Alkaline minipreparations of recombinant clones were analyzed for the correct restriction pattern. One of these plasmids, designated pTiDES3, was used for further experiments. This plasmid was electroporated (according to Mersereau and Pazour, 1990) into Agrobacterium tumefaciens strain R1000 which carries an Ri plasmid. The transformed bacteria were selected on kanamycin LB plates for 2 days at 30 °C. DNA minipreparations of several recombinant bacteria were performed and analyzed as described above to verify the presence of the construct. Young flowering stems of wild type and the fad3 mutant of Arabidopsis were sterilized for 30 min in 10% commercial bleach, 0.02% Triton X100, and 2-cm explants that contained the flowering stem were infected with R1000 (pTiDES3) This was performed by dipping the sectioned extremity in a drop of an overnight culture of the appropriate Agrobacterium that was grown from a single colony in LB medium supplemented with 50 ug/ml Kanamycin. The infected stems were cultured for two days on solid MSO medium (Gibco MS salts plus Gamborg B5 vitamins, 3% sucrose and 0.8% agar). At this time the stem segments were transferred for 5 weeks to MSO medium containing 200 μg/ml cefotaxime to kill the bacterium. After approximately two weeks, most of the stem explants had developed rooty tumors resulting from transfer of parts of the Ri plasmid into cells of the stem explants. In order to identify the rooty tumors which had also received the binary Ti plasmid pTiDES3, approximately 24 rooty tumors from each treatment were transferred to MSO medium containing 50 μg/ml of kanamycin to select for the growth of those roots which had been cotransformed with the binary Ti plasmid; the medium contained also 200 μg/ml of cefotaxime to inhibit bacterial growth. Following a further period of growth for 2 weeks, fatty acid methyl esters were prepared (as described above) from the roots for analysis by gas chromatography. The results of these analyses are presented in Table 2. Table 2. Genoty e Table 2 shows the fatty acid composition of transgenic roots. The transgenic roots resulting from infection of wild type or the fad3 mutant with A. tumefaciens R1000 carrying the vector (pBI121) or the plasmid pTiDES3 were grown in the presence of kanamycin (50 g/ml) for three weeks to identify the roots which had been cotransformed with one of these plasmids. The fatty acid composition of the roots was determined as previously described (Browse et al., 1986). The abbreviations used in Table 2 are as foUows: 16:0, palmitic acid; 16:1, palmitoleic acid; 18:0, stearic acid; 18:1, oleic acid; 18:2, linoleic acid; 18:3, linolenic acid. The values presented are the mean ± SD (n=12). From these results it can be seen that the production of rooty tumors containing pBI121 on wild type Arabidopsis or the fad3 mutant had no effect on the fatty acid composition over non-pBI121 containing wild type Arabidopsis or fad3 mutant. By contrast, transformation of the fad3 mutant with the plasmid pTiDES3 resulted in large increases in the content of linolenic acid. In contrast to the linolenic acid content of 6.7 +/- 0.7% in the fad3 mutant transformed with pBI121, the presence of pTiDES3 resulted in accumulation of 42.1% of the fatty acids as linolenic acid. The increased content of linolenic acid was accompanied by a decrease of corresponding magnitude in the content of Hnoleic acid. Thus, it is clear that the fad3 gene encodes a linoleic acid desaturase. Introduction of the fad3 gene into wild type tissues also resulted in significantly increased accumulation of linolenic acid and a corresponding decrease in linoleic acid (Table 2). Thus, it is apparent from these results that the linoleic acid content of plant tissues can be increased by high level expression of a linoleic acid desaturase. In the present embodiment, the fad3 gene was placed under transcriptional control of the constitutive high level CaMV 35S promoter carried on pBI121. The implication from these results is that expression from this promoter raised the level of expression of the fad3 gene to levels higher than are normally achieved by expression from the endogenous fad3 promoter. The results presented here indicate that the fad3 gene has significant utility in genetic modification of higher plants to elevate linolenic acid levels. Example 2 Antisense expression of fad3 gene to decrease linolenic acid levels In order to decrease the linoleic acid desaturase activity by genetic engineering methodology, the cDNA insert of pBNDES3 was cloned into plant expression cassettes in an antisense orientation. A 959bp BglH restriction fragment of pBNDES3 was used in the antisense expression vectors. The fragment is from 152 nucleotides downstream of the initiating methionine codon of the cDNA to a second Bglll restriction site that is located near the C-terminus of the coding region. 189 nucleotides of the coding region are excluded from this fragment. Triple ligations were performed with the fad3 gene fragment to construct two separate plant expression cassettes. A seed specific expression cassette was constructed by insertion of the Bglll fragment of pBNDES3 in an antisense orientation behind the soybean promoter for the α' subunit of β-conglycinin (7S promoter). A 975bp Hindlll to Bglll fragment containing the 7S promoter derived from pMON529 was prepared by digesting with Bglll for 30min at 37 °C followed by addition of Calf Intestinal Alkaline Phosphatase (CIAP) (Boehringer Mannheim). The reaction was allowed to proceed for 20min followed by purification of the linearized DNA using the GeneClean (Bio 101) purification system. The DNA was then digested with Hindlll. A fragment derived from pMON999 containing the NopaHne synthase 3' region and the pUC vector backbone was prepared by digestion with BamHI and treatment with CIAP. The DNA was purified by the GeneClean procedure and digested with Hindlll. The fragment of pBNDES3 was prepared by digestion with Bglll. The three fragments were purified by agarose gel electrophoresis and the GeneClean procedure. 50 to 200ng of the purified fragments were Hgated for one hour at room temperature followed by transformation into the E. coli strain JM101. Resulting transformant colonies were used for plasmid preparation and restriction digestion analysis. Double digestion with Bglll and Ncol was used to screen for transformants containing the fad3 gene in an antisense orientation. One clone was designated as correct and named pMON13801. A second expression cassette was constructed to allow for constitutive expression of the antisense message in plants. A fragment containing the enhanced 35S promoter was prepared from pMON999 by restriction digestion with Hindlll and Bglll followed by treatment with CIAP as above. The correct sized fragment was obtained by agarose gel electrophoresis and the GeneClean procedure. The Bglll to Hindlll vector fragment and the Bglll fragment of pBNDES3 which were purified above were used in this construction. Ligation, transformation and screening of clones were as described above. One clone was designated as correct and named pMON13802. In both pMON13801 and pMON13802, the promoter, fad3 gene and the Nos 3' region can be isolated on a NotI restriction fragment. These fragments can then be inserted into a unique NotI site of the vector pMON17227 to construct glyphosate selectable plant transformation vectors. The vector DNA is prepared by digestion with NotI followed by treatment with CLAP. The fad3 containing fragments are prepared by digestion with NotI, agarose gel electrophoresis and purification with GeneClean. Ligations are performed with approximately lOOng of vector and 200ng of insert DNA for 1.5 hours at room temperature. Following transformation into the E. coli strain LE392, transformants were screen by restriction digestion to identify clones containing the fad3 expression cassettes. Clones in which transcription from the fad3 cassette is in the same direction as transcription from the selectable marker were designated as correct and named pMON13804 (FMV/CP4/E9, 7S/anti fad3 NOS) (Figure 8) and pMON13805 (FMV/CP4/E9, E35S/anti fad3/NOS) (Figure 9). In preparation for transforming canola cells, pMON 13804 and pMON13805 were mated into Agrobacterium ABI by a triparental mating with the helper plasmid pRK2013. Seeds from the plants produced by transformation were analyzed for alterations in fatty acid profile. Fatty acid methyl esters (FAMES) were prepared from seed tissue and analyzed by capillary gas chromatography (Browse et al, 1986). For initial screening of plants, six seeds were pooled together from an individual plant. The seeds were crushed and FAMES extracts were made. Control plants, plants transformed with the selectable marker only (pMONl7227), were also analyzed using the identical procedure. From the initial screen on pooled seed samples, several lines were identified which displayed a decreased level of linolenic acid. Lines with decreased levels of linolenic acid were reanalyzed by determining fatty acid profiles from individual seeds. Four to twenty individual seed were analyzed from candidate lines and from selected control plants. The results of the FAMES analysis is summarized in Figure 9. Figure 9 shows the levels of fatty acids expressed in molar percent of twenty individual seed of the transgenic line 13804-51 as compared to control seed. Panel A discloses oleic acid, panel B discloses Hnoleic acid and panel C discloses Hnolenic acid. The data in Figure 9 demonstrate that antisense expression of a Hnoleic acid desaturase has significantly altered the fatty acid profile of the resulting seed tissue. The percent of linolenic acid has been reduced to a little over 2% of the total fatty acid in the seed tissue. The percent of linoleic acid has been reduced slightly and surprisingly, the percent of oleic acid in the seed has been increased to approximately 70%. This demonstrates the applicability of utilizing the fad3 gene to manipulate the fatty acid profile of crop plants. In order to demonstrate that the alteration in the fatty acid profile of the FAMES extracted from total seed tissue would be reflected in the seed oil fraction, triglycerides from seeds of fad3 antisense plants were characterized. Total lipid extracts were made by pooling ten seeds and grinding in 2ml of methanol: chloroform: water (4:2:1). The homogenate was allowed to stand for 20min and then debris was pelleted and discarded. To the supernatant 400μl of chloroform:methanol (2:1), 640μl of chloroform and 740μl of water was added and vortexed. Phases were separated by centrifugation and the chloroform phase was recovered and dried under nitrogen. Samples were resuspended in lOOμl of chloroform and lOμl was applied to silica gel G thin layer chromatography plates for separation. Two identical plates were prepared with one being charred after development to allow for alignment and location of spots to be analyzed on the other plate. Plates were developed three times in petroleum ether:diethyl etheπacetic acid (90:10:1). One plate was sprayed with 50% sulfuric acid and heated in an oven at 90°C to allow for detection of Hpids. Triglyceride fractions were identified as comigrating on the plate with purchased Hpid standards (Sigma Chemical Co, cat #178-13). The charred plate was aHgned with the identical plate and the triglyceride fractions were scraped from the plate. The fatty acids were transesterified to produce FAMES extracts for GC analysis by the same procedure as above. The fatty acid profiles of the triglyceride fractions are shown in Table 3 and demonstrate that this fraction have decreased Hnolenic acid. TABLE 3 Table 3 compares the fatty acid molar percentages of triglyceride fractions from control and transgenic lines. These above results provide clear evidence that the fad3 gene can be used to decrease the levels of Hnolenic acid in the storage oil of plants. The gene provides a tool for the manipulation of the fatty acid profile of seed storage oil to improve the products derived from the oil. A surprising result of this Example 2 is the effect the antisense fad3 gene has on the oleic acid content. The precise mechanism by which antisense expression of a gene exerts an effect on the activity of an endogenous gene is unclear but is obviously a function of the homόlogy of the sense and antisense gene products. Based upon the above experimental result, it would not be unreasonable to predict that the portion of the fad3 gene antisense message used contained a certain degree of homology with the genes providing the activity of one or more oleate desaturases. Therefore, a further advantage of the above invention is that it is possible that expression of a linoleic acid desaturase antisense message may exert an effect on oleate desaturase activity. The unexpected nature of the reduction in oleic acid desaturase activity from the antisense fad3 plants is most apparent when one compares the fatty acid profiles from the antisense plants and the fad3 mutant of Arabidopsis. The levels of Hnoleic acid in the fad3 mutant plants increased when linoleic acid desaturase activity was eliminated by mutation. This indicates that the activity of the oleate desaturase was not highly effected by the loss of linoleic acid desaturase activity or by the accumulation of Hnoleic acid. In the fad3 mutant of Arabidopsis the level of Hnoleic acid increased when the level of Hnolenic acid decreased. However, a different pattern occurred in the antisense fad3 plants. In plants which exhibit a decreased percent of linolenic acid there is no corresponding increase, and is often a decrease, in the percent of Hnoleic acid. There is an increase in the percent of oleate in the antisense fad3 plants. This would indicate that oleate desaturase activity is depressed in these plants. The effects on the fatty acid profile by the fad3 mutation and the fad3 antisense expression are not equivalent, indicating that antisense expression of a linoleic acid desaturase can depress an oleate desaturase activity in plants. Example 3 Modification of Hnolenic acid levels in soybean The isolation of the fad3 gene from B. napus provides a tool to those with ordinary skill in the art to isolate the corresponding gene or cDNA from other plant species. There are many examples in which genes from one plant species have been used to isolate the homologous genes from another plant species. One such plant which could be improved upon by the modification of the level of linolenic acid is soybean. Soybean oil typically contains linolenic acid at a level of 7-9% of the fatty acid in the oil. This level is undesirable because it promotes instability upon heating and imparts rancidity to the finished product. The levels of Hnolenic acid can be lowered by the expression of the soybean fad3 gene or cDNA in an antisense orientation in the developing seed. The following example describes one method for the isolation of a fad3 cDNA from soybean. However, similar procedures could be followed to isolate a genomic clone which could also be used to decrease the level of linoleic acid desaturase activity by antisense expression of a portion or all of the gene. The fad3 gene from B. napus is used as a probe to screen a cDNA library constructed from soybean mRNA. In order to isolate a cDNA to be used in decreasing linolenic acid in seed, the optimal tissue to use for the isolation of mRNA is developing seed. There is, however, flexibility in the choice of methods and vectors which can be used in the construction and analysis of cDNA libraries (Sambrook et al, 1989). Procedures for the construction of cDNA libraries are available from manufacturers of cloning materials or from laboratory handbooks such as Sambrook et.al, 1989. Once a suitable cDNA library has been constructed from soybean, all or a portion of the fad3 cDNA from B. napus is labeled and used as a probe of the library. DNA fragments can be labeled for radioactive or non-radioactive screening procedures. The library is screened under suitable stringency. Conditions are dependent upon the degree of homology between the fad3 gene of B. napus and soybean. Probe positive clones are plaque purified by standard procedures and characterized by restriction enzyme mapping and DNA sequence analysis. Clones are concluded to be soybean fad3 based upon data obtained from the sequence analysis or by expression in plants. The entire clone or a portion thereof is placed down stream of a promoter sequence in an antisense orientation. Suitable promoters include seed specific promoters, such as the 7S (β-conglycinin) α'-subunit promoter, or less tissue specific promoters, such as the CaMV 35S promoter. An appropriate 3' non-translated region is placed downstream of the antisense cDNA to allow for transcription termination and for the addition of polyadenylated nucleotides to the 3'end of the RNA sequence. This expression cassette is then combined with a selectable or scorable marker gene and soybean cells are transformed by free DNA delivery (Christou et al, 1990) or an Agrobacterium based method of plant transformation (Hinchee et al, 1988). Plants recovered are allowed to set seed and mature seed are used for the production of FAMES by the procedures outlined above. The FAMES extracts are analyzed by gas chromatography to identify plant lines with reduced levels of linolenic acid in the seed. Alternatives to the above methods may include but are not limited to the use of degenerate oHgonucleotides as probes to screen the library. Degenerate oligonucleotide probes would be most optimally designed by choosing short segments of the fad3 amino acid sequence where the degeneracy of the genetic code is limited or by choosing sequences which appear to be highly conserved between the fad3 gene of B. napus and other known linoleic acid desaturases, such as the desaturase from the cyanobacterium Synechocystis. The oHgonucleotides could be labeled and used to probe a soybean cDNA library. Alternatively, degenerate oligonucleotides could be used as primers for the isolation of a portion or all of the soybean cDNA by PCR ampHfication. Similar procedures could be used to isolate the homologous genes from other plant species. Another preferred plant species which could be improved upon by the modification of the level of linolenic acid is flax. Flax oil typically contains Hnolenic acid at a level of 45-65% of the fatty acid in the oil. This level is undesirable because it promotes instability upon heating and imparts rancidity to the finished product. Example 4 Sense expression of fad3 to obtain reduced levels of Hnolenic acid The cloning of the fad3 gene also provides a tool to decrease the levels of linolenic acid via the mechanism of co-suppression. The molecular mechanism of co-suppression occurs when plants are transformed with a gene that is identical or highly homologous to an allele found in the plants genome (Bird and Ray, 1991). There are several examples where expression of a chimeric gene in plants can result in a reduction of the gene product from both the chimeric gene and the endogenous gene(s). Therefore the fad3 gene product of B. napus may be reduced by transformation of B. napus with all or a portion of the fad3 cDNA which has been isolated. The resulting plant has reduced linoleic acid desaturase activity in tissues where the chimeric gene is expressed. The phenotype of reducing the linoleic acid desaturase activity is a reduction in the levels of linolenic acid. The mechanism of co-suppression could be applied to any plant species from which the fad3 gene is cloned and the plant species is transformed with fad3 in a sense orientation. In order to reduce levels of Hnolenic acid by the mechanism of co- suppression, a plant transformation construct is assembled with the fad3 gene or cDNA in a sense orientation. The entire clone or a portion thereof is placed downstream of a promoter sequence in a sense orientation. Suitable promoters include seed specific promoters, such as the 7S (β-conglycinin) α'-subunit promoter, or less tissue specific promoters, such as the CaMV 35S promoter. An appropriate 3' non-translated region is placed downstream of the fad3 gene to allow for transcription termination and for the addition of polyadenylated nucleotides to the 3' end of the RNA sequence. This expression cassette is then combined with a selectable marker gene and B. napus cells are transformed by an Agrobacterium based method of plant transformation. Plants recovered are allowed to set seed and mature seed are used for the production of FAMES which are analyzed by gas chromatography to identify plant Hnes with reduced levels of Hnolenic acid in the seed. Example 5 Isolation of a chloroplast delta 15 desaturase from Arabidopsis A fragment of 959bp was excised from the fad3 cDNA insert using the restriction endonuclease Bglll, and labeled radioactively according to Feinberg and Vogelstein (1983). This fragment was used to probe a cDNA library from Arabidopsis thaliana as described above (Example 1) except that the hybridization temperature was 52° C. Several cDNA clones were positive, and one of them (pVAl) was further characterized. Its deduced amino acid sequence exhibited a strong homology with fad3 except at the N-terminus. The cDNA insert was placed under the control of the 35S promoter in the Ti vector pBI121, and the resulting construct, pBIVA12 was electroporated into Agrobacterium (C58 pGV3101). The bacterium was used to transform the Arabidopsis mutant fadD. For transformation, plants were grown at 22° C with a light intensity of 100/μE/cm- 2 , until bolting (approximately 2 and 1/2 weeks). The stems (lmm- 10mm long) were removed and the plants were inoculated with a drop of an overnight culture of the bacterium. The same operation was repeated 7 days afterwards. The plants were then allowed to set seeds. The seeds were plated (2500 seeds per 150mm petri dish) on MSO plates that contained 50μg ml kanamycin to select for plants that had integrated the construct. One transformant plant was obtained, and the fatty acids from its leaves were analyzed by gas chromatography (Table 4). The results obtained show that the pBIVA12 construct is able to reestablish the levels of Hnolenic and hexadecatrienoic acids in the fadD mutant at a level equal to or superior to the wild type. This demonstrates that pVA12 encodes the fadD gene. fatty acid fadD Table 4 shows the complementation of the fadD mutant. Fatty acids were extracted from leaves of Arabidopsis according to Browse et al (1986) and were quantified (mol%) by gas chromatography. WT stands for the Columbia wild type. Example 6 Isolation of a second chloroplast delta 15 desaturase from Arabidopsis A fragment of 959 bp was excised from the cDNA insert using the restriction endonuclease Bglll, and labelled radioactively according to Feinberg and Vogelstein (1983). This fragment was used to probe a cDNA library from Arabidopsis, exactly as described above (Example 5). Among the several positive clones obtained, the cDNA pVA34 was further characterized. Its deduced amino acid sequence exhibited 71.8% and 79.5% homology with fad3 and fadD, respectively. The N-terminus resembled a chloroplast transit peptide, meaning that this protein is likely to be localized to the chloroplast. The strong homology with fad3 and fadD suggests that the protein is also a delta 15 desaturase. Aside from fad3 and fadD, the only locus known to control delta 15 desaturation is the fadE locus, which controls a temperature-induced delta 15 desaturase. Therefore, it is likely that the cDNA contained within the clone pVA34 corresponds to the fadE locus. Example 7 Linoleic desaturase homology to plant oleic desaturases The linoleic desaturase genes are the first plant desaturases isolated whose proteins enzymatically perform the desaturation of an unsaturated fatty acid precursor. The reaction that linoleic desaturase performs and the cofactors it uses are likely to be very similar for the oleic desaturase reaction. Given the similar reactions, similar substrates and probably similar cofactors, it is likely that the oleic desaturase genes and proteins have homology to the linoleic desaturase genes and proteins. That the genes share homology is supported by the finding that antisense expression of the linoleic acid desaturase message results in higher oleic acids levels, which experimentally indicates homology between the linoleic and oleic desaturases. These factors indicate that the linoleic desaturase protein and nucleic acid sequences provide useful information for isolating other Hpid desaturase genes, particularly oleic desaturase genes. a. Identification of unknown cDNA sequences in databases. Random cDNA sequencing generates a large number of sequenced clones but provides no information about the function of the encoded proteins. Homology to known proteins is the quickest method for identifying the protein function encoded in the sequenced cDNA. However, homology searches are informative only when a homology with a previously characterized protein are found. A cDNA sequence that is not homologous to any known protein remains in the unknown function category. Thus the results functionally identifying the linoleic desaturases by sequence and by their ability to complement mutations in plant desaturase genes now provides a method for identifying the function and identity of random cDNA clones by their homology to the linoleic desaturases. Additionally oleic desaturases are identified by their homology with linoleic desaturases. A TFASTA search of the GenBank and EMBL public data bases for genes encoding proteins homologous to the protein sequence of the linoleic desaturase fad3 has identified both linoleic desaturases and a second class of plant lipid desaturases likely to be oleic desaturases. In particular, sequences found in GenBank and EMBL and identified as T04093 and T12950 show significant homology to linoleic desaturases but show less homology than other linoleic desaturases. These sequences have 30% homology to fad3 and 56% similarity to fad3 linoleic desaturase (TABLE 5). The full length clone of these cDNAs is obtained by standard methods and is inserted into plant gene expression and transformation vectors and transformed into fad2 Arabidopsis mutants to confirm the identity of the oleic desaturase by genetic complemention as was described in the example with linoleic desaturase. TABLES Comparison of Fad3 and T04093 Protein Sequences Percent Similarity: 52.381% Percent Identity: 30.476% fad3 101 GHGSFSDIPLLNSWGHILHSFI VPYHGWRISHRTHHQNHGHVENDESW 150 1:1 I 1:1 I II :l:.| I I I I I I : I. I I : T04093 1 IFHSFLLVPYFSWKYSHRRHHSNTGSLERDEVF 34 151 VPLPEKLYKNLP HSTRMLRYTVP PM AYPIY WYRSPGKEGSHF 195 M ••• -I • • • . I : : .. I I . : : I : : I : I I : . . | : . : 35 VPKQKSAIKWYGKYLN PLGRIMMLTVQF.VLGWPLY AFNVSGR... PY 80 196 NPYSSLFAPSERKLIATSTTCWSIMLATLVYLSF VDPVTVLKVYGVPYI 245 : . : . : I I : . : : . : 81 DGFACHFFPNAPIYNDRERSRYTSLMRVF* no b. Isolation of a oleic desaturase cDNA. The protein sequence of plant linoleic desaturases can be used to isolate oleic desaturases. The conserved regions between the linoleic desaturases and the DesA oleic desaturase are functionally important and are conserved in the plant oleic desaturase proteins as well. These conserved amino acid sequences provide a method of isolating plant oleic desaturases. There are several regions of the linoleic desaturase fad3 that are conserved in fadD, fadE and DesA. The consensus amino acid sequence is shown in Table 6, with the amino acids identical in all four proteins shown in capital letters. As described below, oHgonucleotides designed to encode the amino acids sequences in the conserved regions are used to identify and isolate plant oleic desaturases. TABLE 6 Pad3 Protein Sequence and Peptide Targets MWA DQRSNVNGDSGARKEEGFDPSAQPPFKIGDIRAAIPKHC VKSP RSMSYVTRD v . tplttp ... spseed .. erf dpgapppf . laDIraaiPKhCwvKnpwksmsyVvrd DIraaiPKhCwvK (la) DIraaiP (lb) aiPKhC (lc) KhCwvK IFAVAALAMAAVYFDS FL PLY VAQGTLF AIFVLGHDCGHGSFSDIPLLNSWGHIL va . vf alaa . aay f nn . lwPly . aqGTmf walFVlGHDCGHgSFsndp . INΞWGH .1 flwPlvWvaσGT FVlGHDCGHσSF (2a) flwPly (3a) FV1GHD (2b) fl P (3b) V1GHDC (2c) wPly (3c) GHDCGH (2d) WvaqGT (3d) CGHgSF HSFILVPYHG RISHRTHHQNHGHVE DES VPLPEKLYKN PHSTR LRYTVPLPMLAY hssilvPyHgWRisHrtHHqnhghvEnDesWhPl.ekiyknlpk.trmfrftlplpmlay PvHσ RisHrtHH EπDes vP (4a) PyHgW (5a) EnDesW (4b) Hg RisH (5b) DesWvP (4c) WRisHrtHH (4d) WRisH (4e) HrtHK PIYL YRSPGKEGSHFNPYSSLFAPSΞRK IATSTTCWSIMLAT. \-ΥLSF VDP\-TV K pfylw.rspgk.gShyhDds.IF-DkerkdvltS ac tamaAl.IvcLnft.gDiσmlK VYGVPYIIFVMWLDAVTYLHHHGHDEKLPWYRGKE SYLRGGL. TIDRDYG.IFNNIH lygiPywifvmWldfvTylHHhghedklpwyrgke SylrggL.tTldrDYg.wmnih ldavTylHH Sylrσσ .tTidrDY (6a) WldavT (7a) WSylrggL (6b) TylHH (7b) L tTidrD (7c) TidrDY HDIGTHVIHHLFPQIPHYHLVDATRAAKHVLGRYYREPKTSGAIPIHLVESLVASIK HDIgtHviHHLfpqIPhYhLveAteaaKpvlGkyyrEpk.sgplplhLlesl.ksik HnTσ HviHHLfnπTPhY !8a) HDIgtH (8b) HviHHL (8c) HHLfpql (8d) HLfpqIP (8e) LfpqIPhY KDHYVSDTGDIVFYETDPDLYVYASDKSKIN* . dhyvsdtGdwyYeadp . lyg . . s* c. Isolation of the fadC (fad6) Gene from Arabidopsis thaliana The fadC gene (also referred to as fad6) encodes a chloroplastic omega-6 desaturase. The deduced amino acid sequences of the fad3 gene from Brassica napus and the fadD and fadE genes from Arabidopsis thaliana were compared with the DesA gene from Synechocystis (Nature, 347:200, 1990). The sequence GHDCGH was determined to represent the most highly conserved region of these proteins. Consequently, a degenerate oligomer was designed that contains all the possible condons for the sequence GHDCGH. This oligomer has the following sequence: GGNCAYGAYTGYGGNCA. An Arabidopsis thaliana cDNA phage library obtained from the laboratory of Dr. Ron Davis (PNAS, 88: 1731-1735) was used to screen for desaturase genes. This library was made using material from all above ground plant parts. Approximately 120,000 phage from the library were plated onto three plates and hybondN+ was then used to prepare three filters from each plate (Molecular Cloning - A Laboratory Manual , 2nd Edition. Eds. J. Sambrook, E. F. Fritsch, and T. Maniatis, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 1989, hereafter "Sambrook"). Two filters from each plate were probed using the degenerate consensus oligomer which had been end-labelled with (32)P using T4 polynucleotide kinase. The hybridizations were performed in a solution that contained high amounts of tetramethylammonium chloride in order to minimize differences in the melting temperatures of the oligomers that together comprise the degenerate consensus oligomer. The hybridization solution had the following composition: 3 M tetramethylammonium chloride, 10 mM sodium phosphate pH 6.8, 1.25 mM EDTA, 0.5% SDS, 0.5% milk. Hybridization was carried out overnight at a temperature of 44 e C. Filters were then washed four times, 20 minutes each time, with 6 x SSC + 0.15% SDS at room temperature. Filters were then washed one time, for 30 minutes, with 4 x SSC + 0.1% SDS at room temperature. The filters were then exposed to film for two days. The third set of filters that were made from each phage- containing plate were probed using DNA sequences from the three Arabidopsis desaturase genes that had already been identified: fad3, fadD and fadE. The fad3, fadD and fadE genes were labelled with (32)P and hybridized to the third set of phage filters in the following hybridization solution: 0.2 M NaCl, 20mM sodium phosphate pH 7.7, 2mM EDTA, 1% SDS, 0.5% milk, 10% dextran sulfate, 0.1% sodium pyrophosphate. Hybridization was carried out overnight at 65 9 C. Filters were washed four times, 30 minutes per time, in 2 x SSC + 0.15% SD at room temperature and then for 45 minutes with 1 x SSC + 0.1% SDS at 65 s C. The filters were then exposed to film for approximately two hours. The two sets of filters that were probed with the degenerate consensus oligomer showed about 60 positive phage per plate (or about 180 total positive phage). Results from the third set of filters that were probed with the fad3, fadD and fadE genes indicated that only a small percentage of the phage that hybridized to the consensus of oligomer contained the fad3, fadD or fadE genes. Seventy-six of the phage that hybridized to the consensus oHgomer, but not to the fad3, fadD or fadE genes, were plaque purified. The purified phage were then spotted onto bacteria growing on solid media on plates and allowed to form plaques. Several duplicate filters were then made of these plates (Sambrook). One of these filters was probed with the consensus oligomer, as described above. A second filter was probed with a mixture of the Arabidopsis thaliana fad3, fadD and fadE genes, as described above. In order to determine which of the 76 phage contained the same cDNA inserts as which other phage, some of the filters were probed with cDNA inserts from some of the phage. In order to perform this experiment, the cDNA inserts from most of the phage were isolated by using oligomers that bound to DNA flanking the cDNA cloning site in the phage vector to isolate the cDNA sequences using the polymerase chain reaction (PCR). These cDNA sequences were labelled with (32)P (random hexamer labelling) and hybridized to the filters using the following hybridization solution: 30% formamide, 0.2M NaCl, 20mM sodium phosphate pH 7.7, 2mM EDTA, 1% SDS, 0.5% milk, 0.1% sodium pyrophosphate. The hybridizations were carried out for 14 hours at 65 2 C. The filters were washed four times 15 minutes per wash, with 2 x SSC + 0.15% SDS at room temperature and were then exposed to film. The combination of the high formamide concentration in the hybridization solution and the high hybridization temperature meant that only DNA sequences that were virtually identical would hybridize, allowing us to distinguish between nearly identical sequences. Several rounds of hybridizations using cDNA inserts from different phage were carried out until it had been determined which phage contained the same, or at least extremely similar, cDNA inserts. On the basis of these experiments, we determined that all of the 76 phage contained one of four cDNA inserts. Sequence data was obtained from each of these four cDNAs. None of these cDNAs was found to be homologous to known desaturase genes, and so we feel that none of these four cDNAs is Hkely to encode a desaturase. Since the number of phage that hybridized to the consensus oligomer was quite high (about 180 phage hybridized in the initial screen described above), we were not able to analyze all of the positive phage in the initial experiments. So, an attempt was made to identify phage that hybridized to the consensus oHgomer but that did not contain the fad3, fadD of fadE genes or one of the four non-desaturase encoding clones that were identified in the first screen. In order to do this, between 500,000 and 1,000,000 phage from the library described above were plated onto 10 plates. Three filters were made from each plate (Sambrook). Two of these three sets of filters were then hybridized with (32) P labelled consensus oligomer as described above except that hybridization was carried out at 42 9 C instead of at 44°C. The third set of filters were hybridized with (32)P labelled DNA from the Arabidopsis fad3, fadD and fadE genes together with DNA from each of the four cDNA's identified in the first round of screening as hybridizing to the consensus oligomer but not encoding desaturases. This third set of filters were hybridized in: 30% formamide, 0.2 M NaCl, 20mM sodium phosphate pH 7.7, 2mM EDTA, 1% SDA, 0.5% milk, 0.1% sodium pyrophosphate at 65 9 C. All three sets of filters were hybridized for 12 hours and then washed several times with 2 x SSC + 0.15% SDS at room temperature. The filters were then exposed to film. Approximately 200 phage from each plate hybridized to the consensus oligomer. 50-60% of these phage also hybridized to fad3, fadD, fadE or to one of the four clones identified in the first screen. About 58 phage that hybridized to the consensus oligomer, but not to fad3, fadD, fadE or one of the four previously identified clones, were plaque purified. The purified phage were then spotted onto a bacterial lawn growing on solid media on a petri plate and the phage were allowed to form plaques. Several filters were prepared from these plates and hybridized with (32 )P labelled cDNA inserts from various of the newly purified phage, as described above. In this manner, all of the phage identified in this second round of screening were found to contain one of eight different cDNA inserts. Sequence data was obtained from each of the eight cDNA's. One of the cDNA's, which was contained within only one of the phage, was found to have some sequence similarity of a known desaturase gene from cyanobacteria, the DesA gene. Further sequence information was obtained for this clone. This additional sequence showed very significant sequence similarity to the DesA gene, confirming that the clone contained a desaturase gene. The remainder of the cDNA contained within the clone was sequenced and compared with the sequences of other known desaturases. The new desaturase was 53.0% identical to DesA at the nucleotide level and 43.9%, 45.6% and 47.0% identical to B. napus fad3, Arabidopsis fadD and Arabidopsis fadE, respectively. As the gene contained within the clone was significantly more similar in sequence to the DesA gene (which is a delta-12 desaturase) than to fad3, fadD or fadE (which are omega-3 desaturases), the new desaturase was expected to be a delta-12 (= omega-6) desaturase. The additional sequence data also indicated that this new desaturase gene contains a region that has only a one base pair mismatch to the desaturase consensus sequence described above. This mismatch means that the new desaturase has the sequence GHDCAH instead of GHDCGH. A clone containing a full length cDNA for this gene was isolated and completely sequenced. This full length cDNA was sub-cloned into the plant transformation vector pBII121 such that the gene is transcribed under the control of the 35S promoter. This construct was then used to complement the phenotype of a fadC mutant (Plant Phys. 90: 522-529, 1989) of Arabidopsis thaliana , indicating that the gene encodes a chloroplastic omega-6 desaturase. d. Proposed isolation of fad2 The most highly conserved peptide regions in the linoleic desaturases and the DesA desaturase were chosen as regions likely to be conserved in oleic desaturases. These 8 conserved regions are shown in TABLE 6. These regions were chosen on the following basis: These regions have areas highly conserved between the 3 Hnoleic desaturases and DesA, with at least 4 identical amino acids over a 10 amino acid span. Once a region was identified as conserved, the fad3 linoleic desaturase sequence was used as the amino acid sequence for the source of homology to identify oleic desaturases. This is because both fad3 and the non-plastid oleic desaturases are thought to be localized to the endoplasmic reticulum and are most Hkely to contain similar amino acid sequences. Several peptide endpoints in each conserved area were chosen as the basis to subsequently design oligonucleotide probes for identifying the oleic desaturase gene. The peptide endpoints were chosen to be between 5 and 9 amino acids in length. The peptide end points were chosen to end on the conserved (identical) amino acids, and most often to begin on conserved amino acids. The rationale is that within the larger conserved area, some amino acid portions are more highly conserved than others, that 15 to 27 (5 to 9 amino acids) nucleotides is a good primer size for PCR, and that for PCR it is important that the 3' end of the primer matches the target, with the conserved (identical) amino acids the most likely to be present in the oleic desaturases. These 28 "oleic desaturase" peptide targets (Table 6) are the basis oHgonucleotides that are designed for hybridizing to the oleic desaturase cDNA sequences to identify and isolate the oleic desaturase cDNA clone. Several possible methods for designing oHgonucleotides and isolating the genes encoding the target peptide regions are known. For a discussion of designing degenerate oHgonucleotides see PCR Protocols - A Guide to Methods and Applications, Eds M. A. Innis, D. H. Gelfand, J J Sninsky and T. J. White, Academic Press, San Diego, California, 1990; and Sanxxxxx The two most common screening methods using the oHgonucleotides are screening cDNA libraries and PCR amplification of specific cDNAs. Gene probes from fad3, fadD and fadE are used under stringent hybridization conditions to identify these cDNAs and discard them in the screen for oleic desaturase cDNA clones. The method for using degenerate oHgonucleotides to screen a cDNA library has been described in the example above demonstrating the isolation of the fadC oleic desaturase gene. An immature plant seed active in oil biosynthesis, generally 2 to 5 weeks after pollination, preferably about 3 to 4 weeks after pollination, of a plant such as Arabidopsis or canola is used as the source of mRNA for making cDNA. First strand cDNA is made from the isolated mRNA and hybridized under stringent conditions in solution to an excess of biotinylated fad3, fadD and fadE cloned cDNAs. The hybrids and biotinylated nucleic acids are removed with strepavidin and a second round of substraction is done to remove any remaining fad3, fadD and fadE sequences. The cDNA remaining in solution is used for PCR reactions. (For 5' RACE, see below, a polyA tail is added to the first strand cDNA 3' end). A method that can readily evaluate a number of degenerate oHgonucleotides probes is degenerate PCR (See chapters by Compton and by Lee and Caskey in PCR Protocols, cited above). In this method a degenerate set of oHgonucleotides encompassing all the possible codon choices for the target peptide is synthesized (such degenerate targets (Table 6) are the basis oHgonucleotides that are designed for hybridizing to the oleic desaturase cDNA sequences to identify and isolate the oleic desaturase cDNA clone. Several possible methods for designing oHgonucleotides and isolating the genes encoding the target peptide regions are known. For a discussion of designing degenerate oHgonucleotides see PCR Protocols - A Guide to Methods and Applications, Eds M. A. Innis, D. H. Gelfand, J J Sninsky and T. J. White, Academic Press, San Diego, CaHfornia, 1990; and Sambrook. The two most common screening methods using the oHgonucleotides are screening cDNA libraries and PCR amplification of specific cDNAs. Gene probes from fad3, fadD and fadE are used under stringent hybridization conditions to identify these cDNAs and discard them in the screen for oleic desaturase cDNA clones. The method for using degenerate oHgonucleotides to screen a cDNA Hbrary has been described in the example above demonstrating the isolation of the fadC oleic desaturase gene. An immature plant seed active in oil biosynthesis, generally 1 to 5 weeks after pollination, preferably about 2 to 4 weeks after polHnation, of a plant such as Arabidopsis or canola is used as the source of mRNA for making cDNA. First strand cDNA is made from the isolated mRNA and hybridized under stringent conditions in solution to an excess of biotinylated fad3, fadD and fadE cloned cDNAs. The hybrids and biotinylated nucleic acids are removed with strepavidin and a second round of substraction is done to remove any remaining fad3, fadD and fadE sequences. The cDNA remaining in solution is used for PCR reactions. (For 5' RACE, see below, a polyA tail is added to the first strand cDNA 3' end). A method that can readily evaluate a number of degenerate oHgonucleotides probes is degenerate PCR (See chapters by Compton and by Lee and Caskey in PCR Protocols, cited above). In this method a degenerate set of oHgonucleotides encompassing all the possible codon TABLE7 Peptide Targets for Fad2 Cloning Oligo sequence 5 ' - 3 ' GAYATH GNGCNGCNATHCC GCNATHCCNAARCAYTG AARCAYTGYTGGGTNAA TGGTTYYTNTGGCCNYTNTAYTGG TGGTTYYTNTGGCCN TGGCCNYTNTAYTGG TGGGTNGCNCARGGNAC TTYGTNYTNGGNCAYGA GTNYTNGGNCAYGAYTG GGNCAYGAYTGYGGNCA TGYGGNCAYGG S TT CCNTAYCAYGGNTGG CAYGGNTGGMGNATH SNCA TGGMGNATHTCNCAYMGNACNCAYCA* TGGMGNATHAGYCAYMGNACNCAYCA* TGGMGNATH SNCAY CAYMGNACNCAYCAY GARAAYGAYGARWSNTGG GAYGARWSNTGGGTNCC NGTNACNGCRTCNARCCA RTGRTGNARRTANGT ARNCCNCCNCKNARRTARCTCCA* ARNCCNCCNCKNARRTANGACCA* RTCNCKRTCDATNGTNGTNA RTARTCNCKRTCDATNGT RTGNGTNCCDATRTCRTG NARRTGRTGDATNACRTG DATYTGNGGRAANARRTGRTG GGDATYTGNGGRAANARRTG RTARTGNGGDATYTGNGGRAANA * synthesize 4c and 7a in two pools each to limit the degeneracy Oligos for 6a - 8e are the complement of the coding sequence TABLE 8 Table of Oligomers for PCR RACE of fad2 Peptide # la lb lc 2a 2b 2c 2d 3a 3b 3c 3d 4a 4b 4c 4d 4e 5a 5b 6a 6b 7a 7b 7c 8a 8b 8c 8d 8e done in two oligo pools Table 7 shows the 28 peptide targets from the eight conserved regions and the 30 degenerate oHgonucleotides derived from the peptide sequences. The degeneracy was kept to less than 516 fold, for those instances where more degeneracy occurred, by the use of deoxyinosine (Sambrook et al.) and by not including the last nucleotide in the last codon, and in two cases by the use of two subpools. Table 8 shows the amount of degeneracy for each designed oligonucleotide sequence and the amount of homology of the oHgonucleotides to the Arabidopsis oleic desaturase fad2 (Accession No. L26296). Also shown in Table 8 is the percent homology in the last 10 nucleotides on the 3' end of each primer, since this region is most important for annealing and elongation under PCR conditions. It is expected that both 10 of 10 and 9 of 10 homology matches, and probably 8 of 10 homology matches in the 3' primer regions will serve as efficient PCR primers. Note that for oHgonucleotide sets la through 5b (for 3' RACE) the strand direction is the same as the mRNA while for oligonucleotide sets 6a through 8e (for 5' RACE) the direction is opposite of the mRNA. Four oHgonucleotides have a 10 of 10 match in the 3' position, 6 oHgonucleotides match 9 of 10 in the 3' position and 12 match in 8 of 10 nucleotides in the 3' position. OHgonucleotides corresponding to peptides 2a, 2c, 2d, 3c, 4b, 4d, 6b, 7c, 8c, and 8d show 90% or greater homology in their last 10 nucleotides and anneal to the oleic desaturase gene and serve as primers to this gene. This demonstrates the validity of using the conserved regions of the plant linoleic desaturases and DesA to identify and isolate plant oleic desaturases. The first round of PCR products are subjected to two rounds of subtraction using biotinylated fad3, fadD and fadE cloned cDNA to remove any hybridizing fad3, fadD and fadE sequences with strepavidin. This subtracted DNA is greatly enriched for fad2 sequences and depleted of fad3, fadD and fadE sequences. These 30 samples are run on agarose gels, blotted and hybridized with pools of probe from the 30 samples. Pools of 5 of each of the 30 PCR samples are labeled with random primers and hybridized to the blots of the 30 samples, for a total of 6 blots hybridized with 6 pools of 5 probes. Additionally, a pool of fad3, fadD and fadE probe is hybridized to a dupHcate blot. Bands that do not hybridize strongly to fad3, fadD and fadE but do cross hybridize to probe made from a different sample are strong candidates for fad2 as fad2 is Hkely to be the only DNA ampHfied in two or more independent PCR reactions. Positively hybridizing lanes identify samples to amplify by PCR using the same primers as in the initial reaction for 5 tolO cycles and the PCR products are cloned into plasmid vectors. The same probe that recognized the sample on the blot is used to screen the library and identify the hybridizing clone. Positive clones are sequenced and identified as fad2 clones by their homology but non-identity with fad3, and further characterized as described below. In the event that fad2 sequences are not sufficiently enriched in one round of PCR to be identified, a second round of PCR is performed. If the lack of detection is due to insufficient amplification of fad2, then another round of PCR using the same primers on the subtracted PCR first round samples and the same simple screen as described above will identify fad2. If there are too many competing non-specific reactions then a second round of PCR using a different primer combination will remove non-specific amplifications and enrich for fad2. To further enrich for fad2 sequences each of the initial 30 PCR samples (one for each oligonucleotide in Table 7) after subtraction as described above, is subjected to a second round of PCR reactions using a different primer combination than the first reaction. One of the primers would be the same degenerate oligonucleotide primer as in the first PCR reaction. The second primer would now be from one of the 30 primers in Table 7 from the opposite class, ie, primers from la to 5b form matched sets with primers from 6a to 8e (primers la to 5b are in the sense direction while primers 6a to 8e are in the antisense direction). For example, if oligonucleotide la was used initially, it is used again as one of the two primers and the second primer is each of the 6a to 8e oHgonucleotides for a total of 11 separate PCR reactions. In total the 30 initial reactions result in 418 second cycle PCR reactions, a number easily handled by PCR technology. Essentially this second PCR cycle accompHshes a "nested" or sequential PCR reaction step after removing all the linoleic desaturases by the subtraction step. This increases the amplification as well as the specificity. Identification of samples containing fad2 are performed similarly as described above, with the 418 samples dot blotted onto 22 filters and probed with 21 pools of 20 samples and with a pool of fad3, fadD and fadE. Again, any sample that cross hybridizes with an independent probe sample and does not hybridize to fad3, fadD and fadE is a candidate for containing fad2 in the sample. If fad3, fadD and fadE hybridization is still present, another biotinylation/stepavidin subtraction should remove it. Positively hybridizing samples are run on gels, the band identified by hybridization and isolated for cloning. This second set of PCR reactions produces PCR products of a predictable size since both primers are within the coding region where little variation in size is expected. Thus the presence of a band of the expected size on a gel is diagnostic of fad2, particularly if hybridization of a blot of such a gel with a fad3, fadD and fadE probe indicates the band is not due to fad3, fadD and fadE contamination. After cloning the inserts in E. coli, the resulting plasmids containing the insert are identified by hybridization. They are sequenced and identified as oleic desaturases by their homology but non-identity with the linoleic desaturases, as in the examples described previously. The full length clone of these cDNAs is obtained by standard methods and inserted into plant gene expression and transformation vectors and transformed into Arabidopsis fad2 mutants to confirm the identity of the oleic desaturase by genetic complemention as was described in the example with Hnoleic desaturase. Thus in this approach to isolating the plant oleic desaturases, the total number of peptide regions is 8, comprised of 28 smaller peptide targets. This leads to set of 30 degenerate oHgonucleotides, that are used in the PCR amplification and screening of the PCR products. Subtraction of interfering fad3, fadD and fadE sequences is used at several points. If necessary a second round of PCR reactions with paired internal primers gives extra amplification and specificity. This approach identifies the plant oleic desaturases, and the sequence of the isolated clones should confirm their identity by their homology to the plant linoleic desaturases as described. Thus a defined approach to isolating the plant oleic desaturases from the information about linoleic desaturases is presented here. The example given here is for Arabidopsis or canola oleic desaturases, but the approach is not limited to those plants as the oleic desaturases are probably highly conserved in most plants. Thus once one plant oleic desaturase is isolated, the sequence information is used to isolate the genes from other plant species by direct hybridization or by an approach similar to the one described here. The following documents, which are cited in the above appHcation, are hereby incorporated by reference. Ammirato, P.V., et al. Handbook of Plant CeU Culture - Crop Species. Macmillan Publ. Co. (1984). Bartlett, S.G., A.R. Grossman, & N.H. Chua. (1982) In Methods in Chloroplast Molecular Biology. Elsevier Biomedical Press, New York, pp 1081-1091. Beachy, R. N., Chen, Z. L., Horsch, R. B., Rogers, S. G., Hoffmann, N. J., and Fraley, R. T. (1985) EMBO J, 4:3047-3053. Benfey, P., Ren, L., and Chua, N.H. (1989) EMBO J, Vol.5, no.8, pp 2195-2202. Bevan, M. (1984) Nucleic Acids Res. 12 (22): 8711-8721. Bird, C. R., and Ray, J. A. (1991) Biotech. Gen. Engin. Rev. 9:207-227. Bray, E. A., Naito, S., Pan, N. S., Anderson, E., Dube, P., and Beachy, R. N. (1987) Planta 172:364-370. Browse J., McCourt P., Somerville C. R. (1985) Science 227:763-65. Browse, J., P.J. McCourt, CR. Somerville. (1986) Anal. Biochem. 152:141- 146. Browse, J., P. McCourt, CR. Somerville. (1986b) Plant Physiol. 81:859- 864 . Browse, J. A., Slack, C. R. (1981.) FEBS Lett. 131:111-14 Browse, J., Somerville, CR. (1991) Ann. Rev. Plant Physiol. Mol. Biol. 42:467-506 . Chang, , Bowman, J.L., DeJohn, A.W., Lander, E.S., Meyerowitz, E.M. (1988) Proc Natl Acad Sci USA 85:6856-6860 Christou, P., McCabe, D. E., MartineU, B. J., and Swain, W. F. (1990) Trends Biotechnol 8:145-151. Church, G.M., and Gilbert, W. (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995 Doyle, J. J., Schuler, M. A., Godette, W. D., Zenger, V., and Beachy, R. N. (1986) J Biol Chem 261:9228-9238. Farmer, E. E., and Ryan, C A. (1992) Plant Cell 4:129-134. Fromm, M., (1990) UCLA Symposium on Molecular Strategies for Crop Improvement, April 16-22, 1990. Keystone, CO. GriU, E., and CR. Somerville (1991) Molec. Gen. Genet., 226:484-490. Harwood, J. L. (1988) Annu Rev Plant Physiol. 39:101-38 Herrera-Estrella, L., et al. (1983) Nature 303:209 Hinchee, M.A.W., Connor-Ward, D.V., Newell, C.A., McDonnell, R.E., Sato, S. J., Gasser, C.S., Fischoff, D.A., Re, D.B., Fraley, R.T., Horsch, R.B. (1988) Bio/Technology 6:915-922. Horsch, R.B. and H. Klee. (1986) Proc. Natl. Acad. Sci. U.S.A. 83:4428-32. Hugly, S., Kunst, L., and Somerville, C R. (1991) J. Hered. 82:484-488. Hugly, S., and Somerville, C R. (1992) Plant Physiol. 99:197-202. Katagiri, F., E. Lam and N. Chua. (1989) Nature 340:727-730. Kearns, E.V., S. Hugly, CR. Somerville (1991) Arch. Biochem. Biophys., 284:431-436. Klee, H.J., et al. (1985) Bio/Technology 3:637-42. Knutson, D. S., Thompson, G. A., Radke, S. E., Johnson, W. B., Knauf, V. C, and Kridl, J. C (1992) Proc. Natl. Acad. Sci. USA 89:2624-2628. Lemieux, B. M. Miquel, CR. Somerville, J. (1990) Theor. Appl. Genet., 80:234-240. Lipman, D. J., and Pearson, W. R. (1985) Science 227:1435-1441. McKeon T. A. , Stumpf, P. K. (1982) J. Biol. Chem. 257:12141- 47 McCourt, P., Kunst, L., Browse, J., Somerville, C R. (1987) Plant Physiol. 84:353-361. McSheffrey, S.A., McHughen A. and Devine, M.D., (1992) Theor. Appl. Genet., 84:480-486. Meinke, D. W., Chen, J., and Beachy, R. N. (1981) Planta 153:130-139. Mersereau, M., Pazour, J., and Das, A. (1990) Gene 90:149-151. Rogers, S., et al. (1987) In 153 Methods in Enzymology. Edited by H. Weissbach and A. Weissbach. 253: Academic Press. Samac, D.A., CM. Hironaka, P.E. Yallaly and D.M. Shah (1990) Plant Physiol. 93:907-914. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, NY. Shanklin, J., CR. Somerville. (1991) Proc. Natl. Acad. Sci. USA 88:2510- 2514. Schilperoot et al, EPO publication 120,516 Schmidhauser, T.J. and D.R. HeHnski. (1985) J. Bacteriol. 164: 155. Schmidt, H., Heinz, E. (1990a) Plant Physiol. 94:214-20 Schmidt, H., Heinz, E. (1990b) Proc. NatLAcad. Sci. USA. 87:9477-9480. Sherman, F., Fink, J., and Hicks, J. B. (1986) Laboratory Course Manual for Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. Shimamoto, K et al. (1989) Nature 338:274-276. Steponkus, P. L., Lynch, D. V., and Vemura, M. (1990) Phil. Trans. Roy. Soc. Lond. B. 326:571-583. Sukumaran, N.P. and Weiser, C.J. (1972) HortScience 7:467-468. Vasil, V., F. Redway and I. Vasil. (1990) Bio/Technology 8:429-434. Wada, H., Gombos, Z., Murata, N. (1990) Nature 347:200-203. Vollrath, D., Davis, R.W. (1987) Nucleic Acids Res 15:7865-7876. Ward, E.R., Jen, G.C. (1990) Plant Mol Biol 14:561-568. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Monsanto Company (B) STREET: 800 North Lindbergh Boulevard (C) CITY: St. Louie (D) STATE: Missouri (E) COUNTRY: United States of America (F) POSTAL CODE (ZIP): 63167 (G) TELEPHONE: (314)694-3131 (H) TELEFAX: (314)694-5435 (ii) TITLE OF INVENTION: Altered Linolenic and Linoleic Acid Content in Plants (iii) NUMBER OF SEQUENCES: 72 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.25 (EPO) (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/156551 (B) FILING DATE: 22-NOV-1993 (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/014431 (B) FILING DATE: 05-FEB-1993 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1353 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 87..1238 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: AATCCATCAA ACCTTTATTC ACCACATTTC ACTGAAAGGC CACACATCTA GAGAGAGAAA 60 CTTCGTCCAA ATCTCTCTCT CCAGCG ATG GTT GTT GCT ATG GAC CAG CGC AGC 113 Met Val Val Ala Met Asp Gin Arg Ser 1 5 AAT GTT AAC GGA GAT TCC GGT GCC CGG AAG GAA GAA GGG TTT GAT CCA 161 Aβn Val Aβn Gly Asp Ser Gly Ala Arg Lys Glu Glu Gly Phe Asp Pro 10 15 20 25 AGC GCA CAA CCA CCG TTT AAG ATC GGA GAT ATA AGG GCG GCG ATT CCT 209 Ser Ala Gin Pro Pro Phe Lys He Gly Asp He Arg Ala Ala He Pro 30 35 40 AAG CAT TGC TGG GTG AAG AGT CCT TTG AGA TCT ATG AGC TAC GTC ACC 257 Lys His Cys Trp Val Lys Ser Pro Leu Arg Ser Met Ser Tyr Val Thr 45 50 55 AGA GAC ATT TTC GCC GTC GCG GCT CTG GCC ATG GCC GCC GTG TAT TTT 305 Arg Asp He Phe Ala Val Ala Ala Leu Ala Met Ala Ala Val Tyr Phe 60 65 70 GAT AGC TGG TTC CTC TGG CCA CTC TAC TGG GTT GCC CAA GGA ACC CTT 353 Asp Ser Trp Phe Leu Trp Pro Leu Tyr Trp Val Ala Gin Gly Thr Leu 75 80 85 TTC TGG GCC ATC TTC GTT CTT GGC CAC GAC TGT GGA CAT GGG AGT TTC 401 Phe Trp Ala He Phe Val Leu Gly His Asp Cys Gly His Gly Ser Phe 90 95 100 105 TCA GAC ATT CCT CTG CTG AAC AGT GTG GTT GGT CAC ATT CTT CAT TCA 449 Ser Asp He Pro Leu Leu Asn Ser Val Val Gly His He Leu His Ser 110 115 120 TTC ATC CTC GTT CCT TAC CAT GGT TGG AGA ATA AGC CAT CGG ACA CAC 497 Phe He Leu Val Pro Tyr His Gly Trp Arg He Ser His Arg Thr His 125 130 135 CAC CAG AAC CAT GGC CAT GTT GAA AAC GAC GAG TCT TGG GTT CCG TTG 545 His Gin Asn His Gly His Val Glu Asn Asp Glu Ser Trp Val Pro Leu 140 145 150 CCA GAA AAG TTG TAC AAG AAC TTG CCC CAT AGT ACT CGG ATG CTC AGA 593 Pro Glu Lys Leu Tyr Lys Asn Leu Pro His Ser Thr Arg Met Leu Arg 155 160 165 TAC ACT GTC CCT CTG CCC ATG CTC GCT TAC CCG ATC TAT CTG TGG TAC 641 Tyr Thr Val Pro Leu Pro Met Leu Ala Tyr Pro He Tyr Leu Trp Tyr 170 175 180 185 AGA AGT CCT GGA AAA GAA GGG TCA CAT TTT AAC CCA TAC AGT AGT TTA 689 Arg Ser Pro Gly Lys Glu Gly Ser His Phe Asn Pro Tyr Ser Ser Leu 190 195 200 TTT GCT CCA AGC GAG AGG AAG CTT ATT GCA ACT TCA ACT ACT TGC TGG 737 Phe Ala Pro Ser Glu Arg Lys Leu He Ala Thr Ser Thr Thr Cys Trp 205 210 215 TCC ATA ATG TTG GCC ACT CTT GTT TAT CTA TCG TTC CTC GTT GAT CCA 785 Ser He Met Leu Ala Thr Leu Val Tyr Leu Ser Phe Leu Val Asp Pro 220 225 230 GTC ACA GTT CTC AAA GTC TAT GGC GTT CCT TAC ATT ATC TTT GTG ATG 833 Val Thr Val Leu Lys Val Tyr Gly Val Pro Tyr He He Phe Val Met 235 240 245 TGG TTG GAC GCT GTC ACG TAC TTG CAT CAT CAT GGT CAC GAT GAG AAG 881 Trp Leu Asp Ala Val Thr Tyr Leu His His His Gly His Asp Glu Lys 250 255 260 265 TTG CCT TGG TAC AGA GGC AAG GAA TGG AGT TAT TTA CGT GGA GGA TTA 929 Leu Pro Trp Tyr Arg Gly Lys Glu Trp Ser Tyr Leu Arg Gly Gly Leu 270 275 280 ACA ACT ATT GAT AGA GAT TAC GGA ATC TTC AAC AAC ATC CAT CAC GAC 977 Thr Thr He Asp Arg Asp Tyr Gly He Phe Asn Asn He His His Asp 285 290 295 ATT GGA ACT CAC GTG ATC CAT CAT CTT TTC CCA CAA ATC CCT CAC TAT 1025 He Gly Thr His Val He His His Leu Phe Pro Gin He Pro His Tyr 300 305 310 CAC TTG GTC GAT GCC ACG AGA GCA GCT AAA CAT GTG TTA GGA AGA TAC 1073 His Leu Val Asp Ala Thr Arg Ala Ala Lys His Val Leu Gly Arg Tyr 315 320 325 TAC AGA GAG CCG AAG ACG TCA GGA GCA ATA CCG ATT CAC TTG GTG GAG 1121 Tyr Arg Glu Pro Lys Thr Ser Gly Ala He Pro He His Leu Val Glu 330 335 340 345 AGT TTG GTC GCA AGT ATT AAA AAA GAT CAT TAC GTC AGT GAC ACT GGT 1169 Ser Leu Val Ala Ser He Lys Lys Asp His Tyr Val Ser Asp Thr Gly 350 355 360 GAT ATT GTC TTC TAC GAG ACA GAT CCA GAT CTC TAC GTT TAT GCT TCT 1217 Asp He Val Phe Tyr Glu Thr Asp Pro Asp Leu Tyr Val Tyr Ala Ser 365 370 375 GAC AAA TCT AAA ATC AAT TAACTTTTCT TCCTAGCTCT ATTAGGAATA 1265 Asp Lys Ser Lys He Asn 380 AACACTCCTT CTCTTTTACT TATTTGTTTC TGCTTTAAGT TTAAAATGTA CTCGTGAAAC 1325 CTTTTTTTTA TTAATGTATT TACGTTAC 1353 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 383 amino acids (B) TΪPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Val Val Ala Met Asp Gin Arg Ser Asn Val Asn Gly Asp Ser Gly 1 5 10 15 Ala Arg Lys Glu Glu Gly Phe Asp Pro Ser Ala Gin Pro Pro Phe Lys 20 25 30 He Gly Asp He Arg Ala Ala He Pro Lys His Cys Trp Val Lys Ser 35 40 45 Pro Leu Arg Ser Met Ser Tyr Val Thr Arg Asp He Phe Ala Val Ala 50 55 60 Ala Leu Ala Met Ala Ala Val Tyr Phe Asp Ser Trp Phe Leu Trp Pro 65 70 75 80 Leu Tyr Trp Val Ala Gin Gly Thr Leu Phe Trp Ala He Phe Val Leu 85 90 95 Gly His Asp Cys Gly His Gly Ser Phe Ser Asp He Pro Leu Leu Asn 100 105 110 Ser Val Val Gly His He Leu His Ser Phe He Leu Val Pro Tyr His 115 120 125 Gly Trp Arg He Ser His Arg Thr His His Gin Asn His Gly His Val 130 135 140 Glu Asn Asp Glu Ser Trp Val Pro Leu Pro Glu Lys Leu Tyr Lys Asn 145 150 155 160 Leu Pro His Ser Thr Arg Met Leu Arg Tyr Thr Val Pro Leu Pro Met 165 170 175 Leu Ala Tyr Pro He Tyr Leu Trp Tyr Arg Ser Pro Gly Lys Glu Gly 180 185 190 Ser His Phe Asn Pro Tyr Ser Ser Leu Phe Ala Pro Ser Glu Arg Lys 195 200 205 Leu He Ala Thr Ser Thr Thr Cys Trp Ser He Met Leu Ala Thr Leu 210 215 220 Val Tyr Leu Ser Phe Leu Val Asp Pro Val Thr Val Leu Lys Val Tyr 225 230 235 240 Gly Val Pro Tyr He He Phe Val Met Trp Leu Asp Ala Val Thr Tyr 245 250 255 Leu His His His Gly His Asp Glu Lys Leu Pro Trp Tyr Arg Gly Lys 260 265 270 Glu Trp Ser Tyr Leu Arg Gly Gly Leu Thr Thr He Asp Arg Asp Tyr 275 280 285 Gly He Phe Asn Aβn He His His Asp He Gly Thr His Val He His 290 295 300 His Leu Phe Pro Gin He Pro His Tyr His Leu Val Asp Ala Thr Arg 305 310 315 320 Ala Ala Lys His Val Leu Gly Arg Tyr Tyr Arg Glu Pro Lys Thr Ser 325 330 335 Gly Ala He Pro He His Leu Val Glu Ser Leu Val Ala Ser He Lys 340 345 350 Lys Asp His Tyr Val Ser Asp Thr Gly Asp He Val Phe Tyr Glu Thr 355 360 365 Asp Pro Asp Leu Tyr Val Tyr Ala Ser Asp Lys Ser Lys He Asn 370 375 380 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GGCGATGCTG TCGGAATGGA CGATA 25 (2) INFORMATION FOR SEQ ID NO: : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: CTTGGAGCCA CTATCGACTA CGCGATC 27 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: CCGATCTCAA GATTACGGAA T 21 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: TTCCTAATGC AGGAGTCGCA TAAG 24 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: AGGAGTCGCA TAAGGGAG 18 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: GGGAAGTGAA TGGAGAC 17 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1645 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 125..1465 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: GGAAAACACA AGTTTCTCTC ACACACATTA TCTCTTTCTC TATTACCACC ACTCATTCAT 60 AACAGAAACC CACCAAAAAA TAAAAAGAGA GACTTTTCAC TCTGGGGAGA GAGCTCAAGT 120 TCTA ATG GCG AAC TTG GTC TTA TCA GAA TGT GGT ATA CGA CCT CTC CCC 169 Met Ala Asn Leu Val Leu Ser Glu Cys Gly He Arg Pro Leu Pro 1 5 10 15 AGA ATC TAC ACA ACA CCC AGA TCC AAT TTC CTC TCC AAC AAC AAC AAA 217 Arg He Tyr Thr Thr Pro Arg Ser Asn Phe Leu Ser Asn Asn Asn Lys 20 25 30 TTC AGA CCA TCA CTT TCT TCT TCT TCT TAC AAA ACA TCA TCA TCT CCT 265 Phe Arg Pro Ser Leu Ser Ser Ser Ser Tyr Lys Thr Ser Ser Ser Pro 35 40 45 CTG TCT TTT GGT CTG AAT TCA CGA GAT GGG TTC ACG AGG AAT TGG GCG 313 Leu Ser Phe Gly Leu Asn Ser Arg Asp Gly Phe Thr Arg Asn Trp Ala 50 55 60 TTG AAT GTG AGC ACA CCA TTA ACG ACA CCA ATA TTT GAG GAG TCT CCA 361 Leu Asn Val Ser Thr Pro Leu Thr Thr Pro He Phe Glu Glu Ser Pro 65 70 75 TTG GAG GAA GAT AAT AAA CAG AGA TTC GAT CCA GGT GCG CCT CCT CCG 409 Leu Glu Glu Asp Asn Lye Gin Arg Phe Asp Pro Gly Ala Pro Pro Pro 80 85 90 95 TTC AAT TTA GCT GAT ATT AGA GCA GCT ATA CCT AAG CAT TGT TGG GTT 457 Phe Asn Leu Ala Asp He Arg Ala Ala He Pro Lys His Cys Trp Val 100 105 110 AAG AAT CCA TGG AAG TCT TTG AGT TAT GTC GTC AGA GAC GTC GCT ATC 505 Lys Asn Pro Trp Lys Ser Leu Ser Tyr Val Val Arg Asp Val Ala He il5 120 125 GTC TTT GCA TTG GCT GCT GGA GCT GCT TAC CTC AAC AAT TGG ATT GTT 553 Val Phe Ala Leu Ala Ala Gly Ala Ala Tyr Leu Asn Asn Trp He Val 130 135 140 TGG CCT CTC TAT TGG CTC GCT CAA GGA ACC ATG TTT TGG GCT CTC TTT 601 Trp Pro Leu Tyr Trp Leu Ala Gin Gly Thr Met Phe Trp Ala Leu Phe 145 150 155 GTT CTT GGT CAT GAC TGT GGA CAT GGT AGT TTC TCA AAT GAT CCG AAG 649 Val Leu Gly Hie Asp Cys Gly His Gly Ser Phe Ser Asn Asp Pro Lys 160 165 170 175 TTG AAC AGT GTG GTC GGT CAT CTT CTT CAT TCC TCA ATT CTG GTC CCA 697 Leu Asn Ser Val Val Gly His Leu Leu His Ser Ser He Leu Val Pro 180 185 190 TAC CAT GGC TGG AGA ATT AGT CAC AGA ACT CAC CAC CAG AAC CAT GGA 745 Tyr His Gly Trp Arg He Ser His Arg Thr His His Gin Asn His Gly 195 200 205 CAT GTT GAG AAT GAC GAA TCT TGG CAT CCT ATG TCT GAG AAA ATC TAC 793 His Val Glu Asn Asp Glu Ser Trp His Pro Met Ser Glu Lys He Tyr 210 215 220 AAT ACT TTG GAC AAG CCG ACT AGA TTC TTT AGA TTT ACA CTG CCT CTC 841 Asn Thr Leu Asp Lys Pro Thr Arg Phe Phe Arg Phe Thr Leu Pro Leu 225 230 235 GTG ATG CTT GCA TAC CCT TTC TAC TTG TGG GCT CGA AGT CCG GGG AAA 889 Val Met Leu Ala Tyr Pro Phe Tyr Leu Trp Ala Arg Ser Pro Gly Lys 240 245 250 255 AAG GGT TCT CAT TAC CAT CCA GAC AGT GAC TTG TTC CTC CCT AAA GAG 937 Lys Gly Ser His Tyr His Pro Asp Ser Asp Leu Phe Leu Pro Lys Glu 260 265 270 AGA AAG GAT GTC CTC ACT TCT ACT GCT TGT TGG ACT GCA ATG GCT GCT 985 Arg Lys Asp Val Leu Thr Ser Thr Ala Cys Trp Thr Ala Met Ala Ala 275 280 285 CTG CTT GTT TGT CTC AAC TTC ACA ATC GGT CCA ATT CAA ATG CTC AAA 1033 Leu Leu Val Cys Leu Asn Phe Thr He Gly Pro He Gin Met Leu Lys 290 295 300 CTT TAT GGA ATT CCT TAC TGG ATA AAT GTA ATG TGG TTG GAC TTT GTG 1081 Leu Tyr Gly He Pro Tyr Trp He Asn Val Met Trp Leu Asp Phe Val 305 310 315 ACT TAC CTG CAT CAC CAT GGT CAT GAA GAT AAG CTT CCT TGG TAC CGT 1129 Thr Tyr Leu His His His Gly His Glu Asp Lys Leu Pro Trp Tyr Arg 320 325 330 335 GGC AAG GAG TGG AGT TAC CTG AGA GGA GGA CTT ACA ACA TTG GAT CGT 1177 Gly Lys Glu Trp Ser Tyr Leu Arg Gly Gly Leu Thr Thr Leu Asp Arg 340 345 350 GAC TAC GGA TTG ATC AAT AAC ATC CAT CAT GAT ATT GGA ACT CAT GTG 1225 Asp Tyr Gly Leu He Asn Asn He His His Asp He Gly Thr His Val 355 360 365 ATA CAT CAT CTT TTC CCG CAG ATC CCA CAT TAT CAT CTA GTA GAA GCA 1273 He His His Leu Phe Pro Gin He Pro His Tyr His Leu Val Glu Ala 370 375 380 ACA GAA GCA GCT AAA CCA GTA TTA GGG AAG TAT TAC AGG GAG CCT GAT 1321 Thr Glu Ala Ala Lys Pro Val Leu Gly Lys Tyr Tyr Arg Glu Pro Asp 385 390 395 AAG TCT GGA CCG TTG CCA TTA CAT TTA CTG GAA ATT CTA GCG AAA AGT 1369 Lys Ser Gly Pro Leu Pro Leu His Leu Leu Glu He Leu Ala Lys Ser 400 405 410 415 ATA AAA GAA GAT CAT TAC GTG AGC GAC GAA GGA GAA GTT GTA TAC TAT 1417 He Lys Glu Asp His Tyr Val Ser Asp Glu Gly Glu Val Val Tyr Tyr 420 425 430 AAA GCA GAT CCA AAT CTC TAT GGA GAG GTC AAA GTA AGA GCA GAT TGAAATGAAG 1472 Lys Ala Asp Pro Asn Leu Tyr Gly Glu Val Lys Val Arg Ala Asp 435 440 445 CAGGCTTGAG ATTGAAGTTT TTTCTATTTC AGACCAGCTG ATTTTTTGCT TACTGTATCA 1532 ATTTATTGTG TCACCCACCA GAGAGTTAGT ATCTCTGAAT ACGATCGATC AGATGGAAAC 1592 AACAAATTTG TTTGCGATAC TGAAGCTATA TATACCATAA AAAAAAAAAA AAA 1645 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 446 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: Met Ala Aβn Leu Val Leu Ser Glu Cys Gly He Arg Pro Leu Pro Arg 1 5 10 15 He Tyr Thr Thr Pro Arg Ser Asn Phe Leu Ser Asn Asn Asn Lys Phe 20 25 30 Arg Pro Ser Leu Ser Ser Ser Ser Tyr Lys Thr Ser Ser Ser Pro Leu 35 40 45 Ser Phe Gly Leu Asn Ser Arg Asp Gly Phe Thr Arg Asn Trp Ala Leu 50 55 60 Asn Val Ser Thr Pro Leu Thr Thr Pro He Phe Glu Glu Ser Pro Leu 65 70 75 80 Glu Glu Asp Asn Lys Gin Arg Phe Asp Pro Gly Ala Pro Pro Pro Phe 85 90 95 Asn Leu Ala Asp He Arg Ala Ala He Pro Lys His Cys Trp Val Lys 100 105 110 Asn Pro Trp Lys Ser Leu Ser Tyr Val Val Arg Asp Val Ala He Val 115 120 125 Phe Ala Leu Ala Ala Gly Ala Ala Tyr Leu Asn Aβn Trp He Val Trp 130 135 140 Pro Leu Tyr Trp Leu Ala Gin Gly Thr Met Phe Trp Ala Leu Phe Val 145 150 155 160 Leu Gly Hie Aβp Cys Gly His Gly Ser Phe Ser Aβn Aβp Pro Lys Leu 165 170 175 Aβn Ser Val Val Gly His Leu Leu His Ser Ser He Leu Val Pro Tyr 180 185 190 His Gly Trp Arg He Ser His Arg Thr His His Gin Asn His Gly His 195 200 205 Val Glu Asn Asp Glu Ser Trp His Pro Met Ser Glu Lys He Tyr Asn 210 215 220 Thr Leu Asp Lys Pro Thr Arg Phe Phe Arg Phe Thr Leu Pro Leu Val 225 230 235 240 Met Leu Ala Tyr Pro Phe Tyr Leu Trp Ala Arg Ser Pro Gly Lys Lys 245 250 255 Gly Ser His Tyr His Pro Asp Ser Asp Leu Phe Leu Pro Lys Glu Arg 260 265 270 Lys Asp Val Leu Thr Ser Thr Ala Cys Trp Thr Ala Met Ala Ala Leu 275 280 285 Leu Val Cys Leu Asn Phe Thr He Gly Pro He Gin Met Leu Lys Leu 290 295 300 Tyr Gly He Pro Tyr Trp He Asn Val Met Trp Leu Aβp Phe Val Thr 305 310 315 320 Tyr Leu His His His Gly His Glu Asp Lys Leu Pro Trp Tyr Arg Gly 325 330 335 Lys Glu Trp Ser Tyr Leu Arg Gly Gly Leu Thr Thr Leu Asp Arg Asp 340 345 350 Tyr Gly Leu He Asn Asn He His His Asp He Gly Thr His Val He 355 360 365 Hiβ Hie Leu Phe Pro Gin He Pro Hie Tyr His Leu Val Glu Ala Thr 370 375 380 Glu Ala Ala Lys Pro Val Leu Gly Lys Tyr Tyr Arg Glu Pro Asp Lys 385 390 395 400 Ser Gly Pro Leu Pro Leu His Leu Leu Glu He Leu Ala Lye Ser He 405 410 415 Lye Glu Aβp Hie Tyr Val Ser Aβp Glu Gly Glu Val Val Tyr Tyr Lye 420 425 430 Ala Aβp Pro Aβn Leu Tyr Gly Glu Val Lye Val Arg Ala Aβp 435 440 445 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1525 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 61..1368 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: AGAGAGTGCA AATAGAACGA CAGAGACTTT TTCCTCTTTT CTTCTTGGGA AGAGGCTCCA 60 ATG GCG AGC TCG GTT TTA TCA GAA TGT GGT TTT AGA CCT CTC CCC AGA 108 Met Ala Ser Ser Val Leu Ser Glu Cys Gly Phe Arg Pro Leu Pro Arg 1 5 10 15 TTC TAC CCT AAA CAC ACA ACC TCT TTT GCC TCT AAC CCT AAA CCC ACT 156 Phe Tyr Pro Lys His Thr Thr Ser Phe Ala Ser Asn Pro Lys Pro Thr 20 25 30 TTC AAA TTC AAT CCA CCA CTT AAA CCT CCT TCT TCT CTT CTC AAT TCC 204 Phe Lys Phe Asn Pro Pro Leu Lys Pro Pro Ser Ser Leu Leu Asn Ser 35 40 45 CGA TAT GGA TTC TAC TCT AAA ACC AGG AAC TGG GCA TTG AAT GTG GCA 252 Arg Tyr Gly Phe Tyr Ser Lys Thr Arg Asn Trp Ala Leu Asn Val Ala 50 55 60 ACA CCT TTA ACA ACT CTT CAG TCT CCA TCC GAG GAA GAC ACG GAG AGA 300 Thr Pro Leu Thr Thr Leu Gin Ser Pro Ser Glu Glu Asp Thr Glu Arg 65 70 75 80 TTC GAC CCA GGT GCG CCT CCT CCC TTC AAT TTG GCG GAT ATA AGA GCA 348 Phe Asp Pro Gly Ala Pro Pro Pro Phe Aβn Leu Ala Asp He Arg Ala 85 90 95 GCC ATA CCT AAG CAT TGT TGG GTT AAG AAT CCA TGG ATG TCT ATG AGT 396 Ala He Pro Lys His Cys Trp Val Lys Aβn Pro Trp Met Ser Met Ser 100 105 110 TAT GTT GTC AGA GAT GTT GCT ATC GTC TTT GGA TTG GCT GCT GTT GCT 444 Tyr Val Val Arg Aβp Val Ala He Val Phe Gly Leu Ala Ala Val Ala 115 120 125 GCT TAC TTC AAC AAT TGG CTT CTC TGG CCT CTC TAC TGG TTC GCT CAA 492 Ala Tyr Phe Aβn Aβn Trp Leu Leu Trp Pro Leu Tyr Trp Phe Ala Gin 130 135 140 GGA ACC ATG TTC TGG GCT CTC TTT GTC CTT GGC CAT GAC TGC GGA CAT 540 Gly Thr Met Phe Trp Ala Leu Phe Val Leu Gly Hie Aep Cyβ Gly Hie 145 150 155 160 GGT AGC TTC TCG AAT GAT CCG AGG CTG AAC AGT GTG GCT GGT CAT CTT 588 Gly Ser Phe Ser Asn Aβp Pro Arg Leu Asn Ser Val Ala Gly Hie Leu 165 170 175 CTT CAT TCC TCA ATT CTG GTC CCT TAC CAT GGC TGG AGG ATT AGC CAC 636 Leu Hie Ser Ser He Leu Val Pro Tyr Hie Gly Trp Arg He Ser Hie 180 185 190 AGA ACT CAC CAC CAG AAC CAT GGT CAT GTC GAG AAT GAC GAA TCA TGG 684 Arg Thr Hie Hie Gin Aβn Hie Gly Hie Val Glu Aβn Aep Glu Ser Trp 195 200 205 CAT CCT TTG CCT GAA AGC ATC TAC AAG AAT TTG GAA AAG ACG ACT CAA 732 Hie Pro Leu Pro Glu Ser He Tyr Lye Aβn Leu Glu Lye Thr Thr Gin 210 215 220 ATG TTT AGG TTT ACA CTG CCT TTT CCA ATG CTC GCA TAC CCT TTC TAC 780 Met Phe Arg Phe Thr Leu Pro Phe Pro Met Leu Ala Tyr Pro Phe Tyr 225 230 235 240 TTG TGG AAC AGA AGT CCA GGG AAA CAA GGT TCT CAT TAT CAT CCG GAC 828 Leu Trp Aβn Arg Ser Pro Gly Lye Gin Gly Ser Hie Tyr Hie Pro Aβp 245 250 255 AGT GAC TTG TTT CTT CCA AAA GAG AAG AAA GAT GTT CTG ACA TCA ACT 876 Ser Aep Leu Phe Leu Pro Lys Glu Lys Lys Asp Val Leu Thr Ser Thr 260 265 270 GCC TGT TGG ACT GCA ATG GCT GCT TTG CTT GTT TGT CTC AAC TTT GTC 924 Ala Cys Trp Thr Ala Met Ala Ala Leu Leu Val Cys Leu Asn Phe Val 275 280 285 ATG GGT CCA ATC CAG ATG CTC AAA CTA TAT GGC ATC CCT TAT TGG ATA 972 Met Gly Pro He Gin Met Leu Lys Leu Tyr Gly He Pro Tyr Trp He 290 295 300 TTT GTA ATG TGG TTG GAC TTC GTC ACT TAC TTG CAC CAC CAT GGA CAT 1020 Phe Val Met Trp Leu Asp Phe Val Thr Tyr Leu His His His Gly His 305 310 315 320 GAA GAC AAG CTC CCT TGG TAT CGT GGA AAG GAA TGG AGT TAC CTG AGA 1068 Glu Asp Lys Leu Pro Trp Tyr Arg Gly Lys Glu Trp Ser Tyr Leu Arg 325 330 335 GGA GGG CTC ACA ACA TTA GAT CGT GAC TAC GGA TGG ATC AAT AAC ATC 1116 Gly Gly Leu Thr Thr Leu Asp Arg Asp Tyr Gly Trp He Aβn Aβn He 340 345 350 CAC CAC GAT ATT GGA ACT CAT GTG ATA CAT CAT CTT TTC CCG CAG ATC 1164 Hie Hie Aβp He Gly Thr Hie Val He Hie Hie Leu Phe Pro Gin He 355 360 365 CCA CAT TAT CAT CTA GTA GAA GCA ACA GAA GCA GCT AAA CCA GTA CTA 1212 Pro Hie Tyr Hie Leu Val Glu Ala Thr Glu Ala Ala Lye Pro Val Leu 370 375 380 GGA AAG TAC TAC AGA GAA CCG AAA AAC TCT GGA CCT CTG CCA CTT CAC 1260 Gly Lye Tyr Tyr Arg Glu Pro Lys Aβn Ser Gly Pro Leu Pro Leu Hie 385 390 395 400 TTA CTG GGA AGC CTC ATA AAG AGT ATG AAA CAA GAC CAT TTC GTA AGC 1308 Leu Leu Gly Ser Leu He Lye Ser Met Lye Gin Aep Hie Phe Val Ser 405 410 415 GAT ACA GGA GAT GTC GTG TAC TAT GAG GCA GAT CCA AAA CTC AAT GGA 1356 Aep Thr Gly Asp Val Val Tyr Tyr Glu Ala Aep Pro Lye Leu Aβn Gly 420 425 430 CAA AGA ACA TGAGGACATA CTGCAGTGAA CCAGGCAGAC AAGTTACATA 1405 Gin Arg Thr 435 AATTCATCTT GGCCCATTCA TTATGTTCTT TTTGTTTTGG TGTAAAGCCT TTTCGAGATT 1465 AAAAAAGCAT TAATTTGTAG AAACCTGTGG TAAAACTCTC GATCAAATGA AATAAGATAT 1525 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 435 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: Met Ala Ser Ser Val Leu Ser Glu Cys Gly Phe Arg Pro Leu Pro Arg 1 5 10 15 Phe Tyr Pro Lys His Thr Thr Ser Phe Ala Ser Asn Pro Lys Pro Thr 20 25 30 Phe Lys Phe Aβn Pro Pro Leu Lys Pro Pro Ser Ser Leu Leu Aβn Ser 35 40 45 Arg Tyr Gly Phe Tyr Ser Lye Thr Arg Aβn Trp Ala Leu Aβn Val Ala 50 55 60 Thr Pro Leu Thr Thr Leu Gin Ser Pro Ser Glu Glu Aβp Thr Glu Arg 65 70 75 80 Phe Aep Pro Gly Ala Pro Pro Pro Phe Asn Leu Ala Aβp He Arg Ala 85 90 95 Ala He Pro Lye Hie Cys Trp Val Lye Asn Pro Trp Met Ser Met Ser 100 105 110 Tyr Val Val Arg Aβp Val Ala He Val Phe Gly Leu Ala Ala Val Ala 115 120 125 Ala Tyr Phe Aβn Aβn Trp Leu Leu Trp Pro Leu Tyr Trp Phe Ala Gin 130 135 140 Gly Thr Met Phe Trp Ala Leu Phe Val Leu Gly Hie Aβp Cys Gly Hie 145 150 155 160 Gly Ser Phe Ser Asn Aβp Pro Arg Leu Asn Ser Val Ala Gly Hie Leu 165 170 175 Leu Hie Ser Ser He Leu Val Pro Tyr Hie Gly Trp Arg He Ser Hie 180 185 190 Arg Thr Hie Hie Gin Aβn Hie Gly His Val Glu Asn Asp Glu Ser Trp 195 200 205 His Pro Leu Pro Glu Ser lie Tyr Lys Asn Leu Glu Lys Thr Thr Gin 210 215 220 Met Phe Arg Phe Thr Leu Pro Phe Pro Met Leu Ala Tyr Pro Phe Tyr 225 230 235 240 Leu Trp Asn Arg Ser Pro Gly Lys Gin Gly Ser His Tyr His Pro Asp 245 250 255 Ser Asp Leu Phe Leu Pro Lys Glu Lys Lys Asp Val Leu Thr Ser Thr 260 265 270 Ala Cys Trp Thr Ala Met Ala Ala Leu Leu Val Cys Leu Asn Phe Val 275 280 285 Met Gly Pro He Gin Met Leu Lys Leu Tyr Gly He Pro Tyr Trp He 290 295 300 Phe Val Met Trp Leu Asp Phe Val Thr Tyr Leu His His His Gly His 305 310 315 320 Glu Aβp Lye Leu Pro Trp Tyr Arg Gly Lye Glu Trp Ser Tyr Leu Arg 325 330 335 Gly Gly Leu Thr Thr Leu Aβp Arg Aep Tyr Gly Trp He Aβn Aen He 340 345 350 Hie Hie Aβp He Gly Thr Hie Val He Hie Hie Leu Phe Pro Gin He 355 360 365 Pro Hie Tyr Hie Leu Val Glu Ala Thr Glu Ala Ala Lye Pro Val Leu 370 375 380 Gly Lye Tyr Tyr Arg Glu Pro Lye Aβn Ser Gly Pro Leu Pro Leu Hie 385 390 395 400 Leu Leu Gly Ser Leu He Lye Ser Met Lye Gin Aep Hie Phe Val Ser 405 410 415 Aβp Thr Gly Aep Val Val Tyr Tyr Glu Ala Aβp Pro Lye Leu Aen Gly 420 425 430 Gin Arg Thr 435 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: GAYATHMGNG CNGCNATHCC 20 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) ( i) SEQUENCE DESCRIPTION: SEQ ID NO:14: GCNATHCCNA ARCAYTG 17 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: AARCAYTGYT GGGTNAA 17 (2) INFORMATION FOR SEQ ID NO:16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: TGGTTYYTNT GGCCNYTNTA YTGG 24 (2) INFORMATION FOR SEQ ID NO:17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (eynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17: TGGTTYYTNT GGCCN 15 (2) INFORMATION FOR SEQ ID NO:18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18: TGGCCNYTNT AYTGG 15 (2) INFORMATION FOR SEQ ID NO:19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: TGGGTNGCNC ARGGNAC 17 (2) INFORMATION FOR SEQ ID NO:20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: TTYGTNYTNG GNCAYGA 17 (2) INFORMATION FOR SEQ ID NO:21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: GTNYTNGGNC AYGAYTG 17 (2) INFORMATION FOR SEQ ID NO:22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22: GGNCAYGAYT GYGGNCA 17 (2) INFORMATION FOR SEQ ID NO:23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: TGYGGNCAYG GNWSNTT 17 (2) INFORMATION FOR SEQ ID NO:24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: CCNTAYCAYG GNTGG 15 (2) INFORMATION FOR SEQ ID NO:25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: CAYGGNTGGM GNATHWSNCA 20 (2) INFORMATION FOR SEQ ID NO:26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 baβe pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: TGGMGNATHT CNCAYMGNAC NCAYCA 26 (2) INFORMATION FOR SEQ ID NO:27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27: TGGMGNATHA GYCAYMGNAC NCAYCA 26 (2) INFORMATION FOR SEQ ID NO:28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 baβe pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: TGGMGNATHW SNCAY 15 (2) INFORMATION FOR SEQ ID NO:29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: CAYMGNACNC AYCAY 15 (2) INFORMATION FOR SEQ ID NO:30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 baβe pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30: GARAAYGAYG ARWSNTGG 18 (2) INFORMATION FOR SEQ ID NO:31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 baβe pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31: GAYGARWSNT GGGTNCC 17 (2) INFORMATION FOR SEQ ID NO:32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 baβe pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32: NGTNACNGCR TCNARCCA 18 (2) INFORMATION FOR SEQ ID NO:33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 baβe pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33: RTGRTGNARR TANGT 15 (2) INFORMATION FOR SEQ ID NO:34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34: ARNCCNCCNC KNARRTARCT CCA 23 (2) INFORMATION FOR SEQ ID NO:35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35: ARNCCNCCNC KNARRTANGA CCA 23 (2) INFORMATION FOR SEQ ID NO:36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36: RTCNCKRTCD ATNGTNGTNA 20 (2) INFORMATION FOR SEQ ID NO:37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 baβe pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37: RTARTCNCKR TCDATNGT 18 (2) INFORMATION FOR SEQ ID NO:38: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38: RTGNGTNCCD ATRTCRTG 18 (2) INFORMATION FOR SEQ ID NO:39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39: NARRTGRTGD ATNACRTG 18 (2) INFORMATION FOR SEQ ID NO: 0: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 baβe pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (synthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40: DATYTGNGGR AANARRTGRT G 21 (2) INFORMATION FOR SEQ ID NO:41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: βingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (βynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41: GGDATYTGNG GRAANARRTG 20 (2) INFORMATION FOR SEQ ID NO:42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 baβe pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (eynthetic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42: RTARTGNGGD ATYTGNGGRA ANA 23 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: Asp He Arg Ala Ala He Pro 1 5 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44: 1 5 (2) INFORMATION FOR SEQ ID NO:45: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45: Lys His Cys Trp Val Lys 1 5 (2) INFORMATION FOR SEQ ID NO:46: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:46: Trp Phe Leu Trp Pro Leu Tyr Trp 1 5 (2) INFORMATION FOR SEQ ID NO:47: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acidβ (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide ( i) SEQUENCE DESCRIPTION: SEQ ID NO:47: Trp Phe Leu Trp Pro 1 5 (2) INFORMATION FOR SEQ ID NO:48: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48: Trp Pro Leu Tyr Trp 1 5 (2) INFORMATION FOR SEQ ID NO:49: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:49: Trp Val Ala Gin Gly Thr 1 5 (2) INFORMATION FOR SEQ ID NO:50: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50: Trp Val Ala Gin Gly Thr 1 5 (2) INFORMATION FOR SEQ ID NO:51: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:51: 1 5 (2) INFORMATION FOR SEQ ID NO:52: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:52: Gly His Asp Cys Gly His 1 5 (2) INFORMATION FOR SEQ ID NO:53: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:53: Cys Gly His Gly Ser Phe 1 5 (2) INFORMATION FOR SEQ ID NO:54: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:54: Pro Tyr His Gly Trp 1 5 (2) INFORMATION FOR SEQ ID NO:55: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:55: His Gly Trp Arg He Ser His 1 5 (2) INFORMATION FOR SEQ ID NO:56: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:56: Trp Arg He Ser His Arg Thr His His 1 5 (2) INFORMATION FOR SEQ ID NO:57: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:57: Trp Arg He Ser His 1 5 (2) INFORMATION FOR SEQ ID NO:58: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:58: His Arg Thr Hie Hie 1 5 (2) INFORMATION FOR SEQ ID NO:59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acidβ (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:59: 1 5 (2) INFORMATION FOR SEQ ID NO:60: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 60 : 1 5 (2) INFORMATION FOR SEQ ID NO:61: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:61: Trp Leu Asp Ala Val Thr 1 5 (2) INFORMATION FOR SEQ ID NO:62: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:62: Thr Tyr Leu His His 1 5 (2) INFORMATION FOR SEQ ID NO:63: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:63: Trp Ser Tyr Leu Arg Gly Gly Leu 1 5 (2) INFORMATION FOR SEQ ID NO:64: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:64: 1 5 (2) INFORMATION FOR SEQ ID NO:65: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:65: 1 5 (2) INFORMATION FOR SEQ ID NO:66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:66: 1 5 (2) INFORMATION FOR SEQ ID NO:67: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 -amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:67: Hie Val He Hie Hie Leu 1 5 (2) INFORMATION FOR SEQ ID NO:68: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:68: Hie Hie Leu Phe Pro Gin He 1 5 (2) INFORMATION FOR SEQ ID NO:69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:69: Hie Leu Phe Pro Gin He Pro 1 5 (2) INFORMATION FOR SEQ ID NO:70: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide ( i) SEQUENCE DESCRIPTION: SEQ ID NO:70: Leu Phe Pro Gin He Pro His Tyr 1 5 (2) INFORMATION FOR SEQ ID NO:71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1670 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 46..1302 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:71: CAAACTCTCT CGGGGGGTCG CTTCTTCTGC ATTTTCTGCT TCCCA ATG GCT TCC 54 Met Ala Ser 1 AGA ATT GCT GAT TCT CTC TTC GCC TTC ACG GGC CCA CAG CAA TGT CTT 102 Arg He Ala Aβp Ser Leu Phe Ala Phe Thr Gly Pro Gin Gin Cyβ Leu 5 10 15 CCT AGG GTT CCT AAG CTT GCT GCT TCT TCT GCT CGT GTT TCT CCT GGT 150 Pro Arg Val Pro Lye Leu Ala Ala Ser Ser Ala Arg Val Ser Pro Gly 20 25 30 35 GTA TAT GCT GTG AAG CCG ATT GAT CTT CTG TTA AAA GGA CGA ACT CAT 198 Val Tyr Ala Val Lye Pro He Aβp Leu Leu Leu Lye Gly Arg Thr Hie 40 45 50 CGA AGT AGA AGA TGT GTA GCT CCT GTG AAA AGG AGA ATT GGA TGT ATC 246 Arg Ser Arg Arg Cyβ Val Ala Pro Val Lye Arg Arg He Gly Cyβ He 55 60 65 AAA GCG GTG GCT GCT CCA GTT GCA CCG CCT TCA GCT GAC AGT GCA GAA 294 Lye Ala Val Ala Ala Pro Val Ala Pro Pro Ser Ala Aep Ser Ala Glu 70 75 80 GAC AGG GAA CAG TTA GCA GAA AGC TAT GGA TTC AGA CAA ATT GGA GAA 342 Aep Arg Glu Gin Leu Ala Glu Ser Tyr Gly Phe Arg Gin He Gly Glu 85 90 95 GAT CTT CCT GAG AAT GTC ACC TTA AAA GAT ATC ATG GAT ACA CTT CCC 390 Aep Leu Pro Glu Aβn Val Thr Leu Lye Aep He Met Asp Thr Leu Pro 100 105 110 115 AAA GAG GTG TTT GAG ATT GAT GAT CTG AAA GCT TTG AAG TCT GTG TTG 438 Lys Glu Val Phe Glu He Asp Aβp Leu Lye Ala Leu Lye Ser Val Leu 120 125 130 ATA TCT GTG ACT TCA TAC ACT TTG GGG CTC TTC ATG ATT GCA AAA TCG 486 He Ser Val Thr Ser Tyr Thr Leu Gly Leu Phe Met He Ala Lye Ser 135 140 145 CCG TGG TAT CTG CTA CCG TTG GCT TGG GCA TGG ACA GGA ACT GCA ATT 534 Pro Trp Tyr Leu Leu Pro Leu Ala Trp Ala Trp Thr Gly Thr Ala He 150 155 160 ACC GGG TTC TTT GTG ATA GGT CAT GAT TGT GCA CAT AAG TCA TTT TCA 582 Thr Gly Phe Phe Val He Gly His Asp Cyβ Ala Hie Lye Ser Phe Ser 165 170 175 AAG AAC AAA TTG GTG GAA GAC ATT GTG GGT ACT CTC GCC TTC CTA CCA 630 Lye Aβn Lye Leu Val Glu Aep He Val Gly Thr Leu Ala Phe Leu Pro 180 185 190 195 CTT GTC TAC CCA TAT GAG CCA TGG CGG TTT AAG CAC GAC CGC CAT CAC 678 Leu Val Tyr Pro Tyr Glu Pro Trp Arg Phe Lye Hie Aβp Arg Hie Hie 200 205 210 GCC AAA ACC AAC ATG TTA CTT CAT GAC ACA GCT TGG CAG CCA GTT CCG 726 Ala Lye Thr Aβn Met Leu Leu His Asp Thr Ala Trp Gin Pro Val Pro 215 220 225 CCA GAG GAG TTT GAG TCA TCA CCC GTG ATG AGA AAG GCA ATC ATT TTT 774 Pro Glu Glu Phe Glu Ser Ser Pro Val Met Arg Lys Ala He He Phe 230 235 240 GGA TAT GGC CCA ATT AGA CCT TGG TTG TCC ATA GCT CAC TGG GTG AAC 822 Gly Tyr Gly Pro He Arg Pro Trp Leu Ser He Ala His Trp Val Asn 245 250 255 TGG CAC TTC AAT CTG AAA AAG TTC AGA GCG AGC GAG GTG AAT AGG GTG 870 Trp Hie Phe Aβn Leu Lye Lye Phe Arg Ala Ser Glu Val Aβn Arg Val 260 265 270 275 AAG ATA AGT TTG GCT TGT GTT TTC GCC TTC ATG GCC GTT GGG TGG CCA 918 Lye He Ser Leu Ala Cys Val Phe Ala Phe Met Ala Val Gly Trp Pro 280 285 290 CTG ATC GTA TAC AAA GTT GGT ATA TTG GGA TGG GTA AAA TTC TGG TTA 966 Leu He Val Tyr Lye Val Gly He Leu Gly Trp Val Lye Phe Trp Leu 295 300 305 ATG CCA TGG TTG GGC TAT CAC TTC TGG ATG AGC ACA TTC ACA ATG GTT 1014 Met Pro Trp Leu Gly Tyr Hie Phe Trp Met Ser Thr Phe Thr Met Val 310 315 320 CAT CAT ACG GCT CCG CAT ATA CCT TTC AAG CCT GCG GAT GAG TGG AAC 1062 Hie Hie Thr Ala Pro Hie He Pro Phe Lys Pro Ala Asp Glu Trp Asn 325 330 335 GCG GCT CAG GCC CAG CTG AAT GGA ACT GTT CAT TGT GAC TAC CCT AGT 1110 Ala Ala Gin Ala Gin Leu Asn Gly Thr Val His Cys Aβp Tyr Pro Ser 340 345 350 355 TGG ATT GAA ATT CTC TGC CAT GAT ATC AAC GTT CAC ATC CCG CAT CAT 1158 Trp He Glu He Leu Cys His Asp He Asn Val His He Pro His His 360 365 370 ATT AGC CCA AGA ATA CCG AGC TAC AAT CTC CGT GCA GCT CAT GAG TCT 1206 Ile Ser Pro Arg He Pro Ser Tyr Asn Leu Arg Ala Ala His Glu Ser 375 380 385 ATA CAA GAG AAC TGG GGA AAG TAT ACA AAC TTG GCT ACA TGG AAC TGG 1254 He Gin Glu Aβn Trp Gly Lys Tyr Thr Aβn Leu Ala Thr Trp Aβn Trp 390 395 400 CGA TTG ATG AAG ACG ATA ATG ACT GTG TGT CAT GTC TAT GAC AAA TAGGAGAACT 1309 Arg Leu Met Lys Thr He Met Thr Val Cys Hie Val Tyr Aβp Lys 405 410 415 ACATTCCTTT TGACCGGTTA GCCCCTGAAG AATCTCAGCC AATAACCTTC CTCAAGAAAT 1369 CAATGCCTAA CTACACAGCC TGATTCGCCA TGGTCTCAAA CTAGTCTTTT GAAATCTCAA 1429 TATCTTTTTG CAGTCGCCGA TGTTATATGT AAGCTTTCCA AGCGATGAGC TTCTCTAACA 1489 CTTCACCAAC GCTTTATACT GTTATCTTCT TTCCAATCTT ATCAGAAGAG AGAAACTGGT 1549 CAAATTATCT GAGCGATTGC AATTCTTTTA TCAGTTTCTT AGCTATAAGA AGATTGAACA 1609 GTCTATATAG TTTGCAATGT ACTGTAATGT GATGAAAATT TAGTTGATGA GAAAAAAAAA 1669 A 1670 (2) INFORMATION FOR SEQ ID NO:72: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 418 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:72: Met Ala Ser Arg He Ala Asp Ser Leu Phe Ala Phe Thr Gly Pro Gin 1 5 10 15 Gin Cys Leu Pro Arg Val Pro Lys Leu Ala Ala Ser Ser Ala Arg Val 20 25 30 Ser Pro Gly Val Tyr Ala Val Lys Pro He Asp Leu Leu Leu Lys Gly 35 40 45 Arg Thr His Arg Ser Arg Arg Cys Val Ala Pro Val Lys Arg Arg He 50 55 60 Gly Cys He Lys Ala Val Ala Ala Pro Val Ala Pro Pro Ser Ala Asp 65 70 75 80 Ser Ala Glu Aβp Arg Glu Gin Leu Ala Glu Ser Tyr Gly Phe Arg Gin 85 90 95 Ile Gly Glu Asp Leu Pro Glu Aβn Val Thr Leu Lye Aβp He Met Aβp 100 105 110 Thr Leu Pro Lye Glu Val Phe Glu He Aβp Aβp Leu Lye Ala Leu Lye 115 120 125 Ser Val Leu He Ser Val Thr Ser Tyr Thr Leu Gly Leu Phe Met He 130 135 140 Ala Lye Ser Pro Trp Tyr Leu Leu Pro Leu Ala Trp Ala Trp Thr Gly 145 150 155 160 Thr Ala He Thr Gly Phe Phe Val He Gly Hie Aβp Cyβ Ala Hie Lye 165 170 175 Ser Phe Ser Lye Aβn Lye Leu Val Glu Aβp He Val Gly Thr Leu Ala 180 185 190 Phe Leu Pro Leu Val Tyr Pro Tyr Glu Pro Trp Arg Phe Lye Hie Aβp 195 200 205 Arg Hie Hie Ala Lye Thr Aβn Met Leu Leu Hie Aep Thr Ala Trp Gin 210 215 220 Pro Val Pro Pro Glu Glu Phe Glu Ser Ser Pro Val Met Arg Lye Ala 225 230 235 240 He He Phe Gly Tyr Gly Pro He Arg Pro Trp Leu Ser He Ala Hie 245 250 255 Trp Val Aβn Trp His Phe Asn Leu Lye Lye Phe Arg Ala Ser Glu Val 260 265 270 Aβn Arg Val Lye He Ser Leu Ala Cys Val Phe Ala Phe Met Ala Val 275 280 285 Gly Trp Pro Leu He Val Tyr Lys Val Gly He Leu Gly Trp Val Lys 290 295 300 Phe Trp Leu Met Pro Trp Leu Gly Tyr His Phe Trp Met Ser Thr Phe 305 310 315 320 Thr Met Val Hie Hie Thr Ala Pro His He Pro Phe Lys Pro Ala Asp 325 330 335 Glu Trp Asn Ala Ala Gin Ala Gin Leu Asn Gly Thr Val His Cys Asp 340 345 350 Tyr Pro Ser Trp He Glu He Leu Cys His Asp He Asn Val His He 355 360 365 Pro His His He Ser Pro Arg He Pro Ser Tyr Asn Leu Arg Ala Ala 370 375 380 His Glu Ser He Gin Glu Asn Trp Gly Lys Tyr Thr Asn Leu Ala Thr 385 390 395 400 Trp Asn Trp Arg Leu Met Lys Thr He Met Thr Val Cys His Val Tyr 405 410 415 Asp Lys

Claims: Claims: 1. A genetically transformed plant which has an elevated linolenic acid content comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 2. The plant of claim 1 in which the Hnoleic acid desaturase activity is from plants. 3. The plant of claim 1 in which the linoleic acid desaturase activity is from fungi, algae or bacteria. 4. The plant of claim 1 in which the structural coding sequence of (ii) is taken from SEQ. ID NO:l. 5. The plant of claim 1 in which the structural coding sequence of (ii) is taken from SEQ. ID NO:9. 6. The plant of claim 1 in which the structural coding sequence of (n) is taken from SEQ. ID NO:ll. 7. The plant of claim 1 in which the promoter of (i) is an endogenous plant linoleic acid desaturase promoter. 8. A genetically transformed plant which has a reduced linolenic acid content, comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a Hnoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 9. The plant of claim 8 in which the Hnoleic acid desaturase enzyme is from plants. 10. The plant of claim 8 in which the Hnoleic acid desaturase enzyme is from fungi, algae or bacteria. 11. The plant of claim 8 in which the structural coding sequence of (u) is taken from SEQ. ID NO:l. 12. The plant of claim 8 in which the structural coding sequence of (ii) is taken from SEQ. ID NO:9. 13. The plant of claim 8 in which the structural coding sequence of (ii) is taken from SEQ. 8 ID NO:ll. 14. The plant of claim 8 in which the promoter of (i) is an endogenous plant linoleic acid desaturase promoter. 15. A genetically transformed plant which has an improved resistance to low temperatures comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (iii) a 3' non-translated region that functions in plant ceUs to promote polyadenylation to the 3' end of said RNA sequence. 16. A genetically transformed plant which has an elevated abiHty to respond to pathogens, comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 17. A seed produced from genetically transformed plant where said seed has an linolenic acid content suitable for use as a source of Hnolenic acid, said plant comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (ϋi) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. lδ.The seed of claim 17 where said plant is selected from the group consisting of soybean and rapeseed. 19. A genetically transformed plant which has a linolenic acid content of less than about 3%, said plant comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a linoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 20. A genetically transformed plant which has an increased oleic acid content, comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ϋ) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a oleic acid desaturase activity in said plant; and SUBSTITUTE SHEET ( RULE 26 (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 21. A genetically transformed plant which has an increased oleic acid content, comprising a recombinant, double-stranded DNA molecule comprising (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably linked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a Hnoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 22. A method of producing a genetically transformed plant which has an elevated linolenic acid content, comprising (a) inserting into the genome of a plant cell a recombinant, double-stranded DNA molecule comprising: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence; (b) obtaining transformed plant cells; and (c) regenerating from the transformed plant cells genetically transformed plants which have an elevated Hnolenic acid content. 23. The method of claim 22 in which the linoleic acid desaturase enzyme is from plants. 24. The method of claim 22 in which the linoleic acid desaturase enzyme is from fungi, algae or bacteria. 25. The method of claim 22 in which the structural coding sequence of (H) is taken from SEQ. ID NO: 1. 26. The method of claim 22 in which the structural coding sequence of (fi) is taken from SEQ. ID NO:9. 27. The method of claim 22 in which the structural coding sequence of (n) is taken from SEQ. ID NO:ll. 28. The plant of claim 22 in which the promoter of (i) is an endogenous plant linoleic acid desaturase promoter. 29. A method of producing a genetically transformed plant which has a reduced Hnolenic acid content, comprising (a) inserting into the genome of a plant cell a recombinant, double-stranded DNA molecule comprising: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a linoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence (b) obtaining transformed plant cells; and (c) regenerating from the transformed plant cells genetically transformed plants which have a reduced Hnolenic acid content. 30. The method of claim 29 in which the linoleic acid desaturase enzyme is from plants. 31. The method of claim 29 in which the linoleic acid desaturase enzyme is from fungi, algae or bacteria. 32. The method of claim 29 in which the structural coding sequence of (H) is taken from SEQ. ID NO:l. 33. The method of claim 29 in which the structural coding sequence of (u) is taken from SEQ. ID NO:9. 34. The method of claim 29 in which the structural coding sequence of (u) is taken from SEQ. ID NO:ll. 35. The plant of claim 29 in which the promoter of (i) is an endogenous plant linoleic acid desaturase promoter. 36. A method of producing a genetically transformed plant which has an increased oleic acid content, comprising (a) inserting into the genome of a plant cell a recombinant, double-stranded DNA molecule comprising: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a linoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence (b) obtaining transformed plant cells; and (c) regenerating from the transformed plant cells genetically transformed plants which have an increased oleic acid content. 37. A recombinant, double-stranded DNA molecule comprising in sequence: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a structural coding sequence that causes the production of an RNA sequence that encodes a linoleic acid desaturase activity; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 38. A recombinant, double-stranded DNA molecule comprising in sequence: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a linoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant ceUs to promote polyadenylation to the 3' end of said RNA sequence. 39. A plant cell comprising a recombinant, double- stranded DNA molecule comprising in sequence: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a Hnoleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant cells to promote polyadenylation to the 3' end of said RNA sequence. 40. A method of producing a genetically transformed plant which has an increased oleic acid content, comprising (a) inserting into the genome of a plant cell a recombinant, double-stranded DNA molecule comprising: (i) a promoter that functions in plant cells to cause the production of an RNA sequence, said promoter operably Hnked to; (ii) a DNA sequence that causes the production of an RNA sequence that is in antisense orientation to at least a portion of a gene that encodes a oleic acid desaturase activity in said plant; and (iii) a 3' non-translated region that functions in plant ceUs to promote polyadenylation to the 3' end of said RNA sequence (b) obtaining transformed plant cells; and (c) regenerating from the transformed plant cells genetically transformed plants which have an increased oleic acid content.

Inventors: ARONDEL VINCENT JEAN-MARIE ARM, GIBSON SUSAN IRMA, KISHORE GANESH MURTHY, RUFF THOMAS GENE, SOMERVILLE CHRISTOPHER ROLAND, ARONDEL, VINCENT, JEAN-MARIE, ARMEL;, GIBSON, SUSAN, IRMA, KISHORE, GANESH, MURTHY, RUFF, THOMAS, GENE, SOMERVILLE, CHRISTOPHER, ROLAND
Applicants: ARONDEL VINCENT JEAN MARIE ARM, GIBSON SUSAN IRMA, KISHORE GANESH MURTHY, MONSANTO CO, RUFF THOMAS GENE, SOMERVILLE CHRISTOPHER ROLAND, UNIV MICHIGAN, ARONDEL, VINCENT, JEAN-MARIE, ARMEL;, GIBSON, SUSAN, IRMA, KISHORE, GANESH, MURTHY, MICHIGAN STATE UNIVERSITY, MONSANTO COMPANY, RUFF, THOMAS, GENE, SOMERVILLE, CHRISTOPHER, ROLAND
Application year: 1994
Main classification: C12N15
IPC codes: A01H5, C12N5, C12N9, C12N15